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ABSTRACT

DIVERSE ROLES OF PKCα IN A7r5
SMOOTH MUSCLE CELLS
by Ava Caudill Dykes

A complete understanding of the mechanisms underlying smooth muscle
contractility has proven elusive due to the many interacting factors thought to influence
contractile behavior in this muscle type. One such factor, protein kinase Cα (PKCα), is
proposed to play a central role in both the activation and modulation of smooth muscle
contraction. PKCα is activated through a G-protein coupled receptor and is subsequently
translocated to its site of action. Although the mechanisms regulating PKCα site specific
translocation are not completely understood, it is thought that this process is essential for
PKCα specificity of action within the cell.

In chapter II we discuss our research

demonstrating a PKCα/β-tubulin relationship in the contracting smooth muscle cell.
Here, we show for the first time that PKCα translocation is dependent on an intact system
of microtubules and propose the hypothesis of microtubular involvement in PKCα
translocation. Activation of PKCα in contracting smooth muscle is thought to result in
the phosphorylation of several proteins which could be important in contraction. One
such protein, calponin, is known to influence smooth muscle contractility but its
mechanism of action is not clear. In chapter III, we discuss our research showing the
formation of a PKCα/calponin complex in contracting smooth muscle with associated
losses in α-actin stress fibers and cytoskeletal remodeling. Based on this work, we

propose that calponin plays a major role in the stabilization of stress fibers and that the
release from calponin cross-linking of actin filaments provides a mechanism enabling
actin filament sliding and subsequent cytoskeletal remodeling.
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Chapter I.
General Introduction
Dissertation Organization
This dissertation is divided into four chapters. The first chapter represents a
general review of the literature of relevant topics. Chapter two is a manuscript previously
published in the American Journal of Physiology, Cell Physiology, reproduced with the
kind permission of the American Physiological Society. This chapter describes the
association between β-tubulin and PKCα and reports a novel cell structure dependent on
this interaction. Chapter three is a manuscript recently submitted to Acta Physiologica.
This paper examines PKCα’s association with one of its substrates, calponin (CaP), and
the impact of changes in CaP expression levels on α-actin cytoskeletal structure. Here we
show that calponin may have a novel role in contraction, contributing to actin structural
stability through cross-linking of actin filaments. Chapter four contains a brief discussion
of the results and implications of both manuscripts, as well as recommendations for
future research.
In addition to a discussion of the factors contributing to the unique smooth muscle
(SM) contraction, a review of certain techniques will follow. These methods were
pioneered for use in the study of SM within our laboratory. FRET (fluorescence
resonance energy transfer) microscopy and AFM (atomic force microscopy) were novel
physiological tools at the time of publication and represent the visionary integrative
approaches utilized within the field of cell physiology. Besides a brief review of the
theory behind these tools, their current use and applications will be evaluated.
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Literature Review
Smooth Muscle Contraction
The mechanism of contraction in smooth muscle (SM) is different from other
muscle types. Although the fundamental actin-myosin interaction is the same, with
force production the result of the cyclic interaction of crossbridges formed between actin
and myosin causing these filaments to slide past one another, smooth muscle exhibits a
number of distinctive properties that cannot be accounted for on the basis of models
devised to explain striated or skeletal muscle (SKM) contraction (Gunst and Tang 2000).
One such model is the sliding filament theory. As illustrated in Figure 1, this mechanism
is dependent upon the organization of the contractile protein into a sarcomere. In the
relaxed sarcomere, overlapping actin and myosin filaments lie parallel to each other. In
the contracted state, these filaments greatly overlap and the Z lines appear to have moved
to the ends of the myosin filaments. This configuration is due to the sliding of actin
filaments past the myosin filaments, hence the name sliding filament. Perhaps the most
obvious difference between SM and SKM is the lack of this structured sarcomere. It is
the ordered sarcomere that gives SKM its striated appearance. It is the lack of which that
bestows SM’s “smooth” appearance and therefore its name (Guyton and Hall 2000). It
has been assumed that sarcomere-like structures adjacent to dense bodies constitute the
basic contractile unit in SM. In one such proposed model, Bond and Somlyo (1982)
contend that α-actinin-containing dense bodies are analogous to Z-lines in SKM and thus
demarcate the boundaries of an equivalent sarcomere. However, a repeating, regular
arrangement of actin and myosin has yet to be demonstrated (Draeger et al. 1990).
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Figure 1. Diagram of resting (top) and contracted (bottom) sarcomere structure.
Taken from www.tmd.ac.jp.

One distinguishing feature of SM is that its biochemical sequence of activation
differs from that of SKM (Figure 2). SM lacks the regulatory protein troponin (found in
SKM). Instead, SM contains the Ca++-sensitive regulatory proteins calmodulin (CaM)
and calponin (CaP) (Murphy 1994), to be discussed in a subsequent section. Following
an increase in [Ca++]i, 4 free Ca++ form a complex with calmodulin. This complex (Ca++CaM) activates myosin light chain kinase (MLCK), enabling its kinase activity. Active
MLCK can then phosphorylate the regulatory light chain of the myosin molecule to
induce a conformation change in the myosin head, so that it is positioned to interact with
the actin filament. In the presence of ATP, the Mg++-ATPase activity of the myosin head
will hydrolyze ATP to ADP, producing energy for the actin-myosin power stroke. This
maneuver results in the movement of myosin along the actin filament (Driska et al.
1981). The contributions of calponin (CaP) and PKCα shown in Figure 2 will be
discussed below.
3
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Figure 2. Mechanism of smooth muscle contraction.

Another significant disparity stems from the variable ratio of actin to myosin
among different smooth muscle types. Whereas SKM consistently exhibits a 6:1 ratio of
actin:myosin, smooth muscle shows a range a values for this ratio. For example, the ratio
in chicken gizzard is 8:1, while that in vascular SM is approximately 15:1 (Gunst and
Tang 2000). Ratios as high as 50:1 have been reported in amphibian visceral muscle
(Gunst and Tang 2000). This increased ratio arises, in part, from the reduced myosin
content in SM. Repeated measurements have found that SM has only 1/5 the myosin
content of SKM (Murphy et al. 1974). What makes this notable is the ability of smooth
muscle to produce even greater contractile force than that of skeletal muscle. Moreover,
SM contractile force is produced at markedly reduced energy expenditure, approximately
1/10 to 1/300 that of SKM (Paul 1983). VanBuren et al. (1994) have reported that
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smooth muscle myosin exerts three times greater average force per cross-bridge head
(0.6pN) than SKM myosin (0.2pN), suggesting the mechanism by which high SM force
is achieved. However, their findings have not been verified.
In addition to these differences SM has the remarkable ability to slowly develop
force (Wright and Hurn 1994). Vascular smooth muscle contraction has been shown to
be delineated into two distinct phases, the initial (fast) phase and a secondary (slow)
phase. When studied separately, the fast phase was shown to have a length-tension curve
similar to SKM; whereas, increasing the tissue preload had little effect on active tension
developed in the slow phase of contraction. Cytochalasin, an actin polymerization
inhibitor, selectively prevented tension generation in the slow phase when this tissue was
stimulated by either elevated K+ or PDBu. Similarly, the PKC inhibitor, staurosporine,
also blocked the slow response. These results suggest different mechanisms regulate the
SKM-like fast phase and the unique slow phase of the smooth muscle contraction
(Wright and Hurn 1994). Once established, the tension generated by SM can be
maintained for extended periods at a minimal energy cost, about 0.35% of that expended
by SKM in a comparable contraction (Paul 1983). It has been estimated that the
maintenance of blood pressure would double basal metabolic rate if the energetics of
vascular SM matched those of SKM (Murphy 1994). There is also evidence supporting
the fact that force development and tension maintenance are dissociated from myosin
light chain phosphorylation and myosin ATPase activity (Driska et al. 1981; Merkel et al.
1990). The mechanism of these unique properties of SM is unknown.
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SM may be stretched through a much broader range of lengths than SKM without
significantly affecting active force development. This is illustrated in Figure 3, showing that at
even very short lengths or with high levels of stretch, SM maintains the capability to develop
near optimal levels of active tension. Because the length-tension relationship of muscle is
thought to reflect stretch-induced changes in the relative positions of actin and myosin filaments
within the sarcomere (Davis and Gore 1989), the factors determining this parameter in SM are
not certain.

Figure 3. Comparison of length-tension relationships of smooth muscle with striated (SKM) muscle.
Modified from www.ucl.ac.uk/uro-neph/ppt/is0304/sm11103.ppt.

Finally, SM shows the ability to undergo stress relaxation, the release of tension
following tissue stretch. Aortic rings contracted with either K+ or PDBu exhibited an
approximate 30% decrease in tension generated by passive tissue stretch (Wright and
Battistella-Patterson 1998). The stress-relaxation response could be abolished by the
removal of extracellular Ca++ or treatment with cytochalasin B, an actin polymerization
inhibitor. However, colchicine, a microtubule depolymerizing agent, had no effect.
These results indicated that stress-relaxation in contracted tissue is calcium-dependent
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and may be explained by the remodeling of tension-bearing portions of the actin
cytoskeleton (Wright and Battistella-Patterson 1998).

Cytoskeletal Remodeling
As discussed above, many of the contractile properties of SM indicate that
its mechanism(s) of contraction differ from other muscle types. Unique characteristics
such as slow force development (Wright and Hurn 1994), prolonged tension maintenance
at low energy cost (Paul 1983), a broad length-tension relationship (Battistella-Patterson
et al. 1997), and the property of stress-relaxation (Wright and Battistella-Patterson 1998)
each indicate that contraction of SM cannot be explained solely on the basis of sliding
filament theory. One hypothesis gaining increasing acceptance is that SM contractile
properties are determined by cytoskeletal remodeling. The origins of cytoskeletal
remodeling as a concept in SM contractility can be traced to the work of D. M. Warshaw
(1987). Intrigued by the observation that the velocity of shortening in contracting SM
was much slower than in SKM, he studied the force-shortening velocity relationship in
single SM cells isolated from toad stomach muscularis (Warshaw 1987). The need for
this study arose from the fact that all previous SM studies had been performed on tissue
preparations. Hence the results from these earlier studies represented the average of
many single cell responses coupled with the influence of surrounding ground tissue and
could differ from that of a single cell. Warshaw’s work showed that SM slow shortening
velocity occurs independent of time after stimulation and was not due to reduced forcegenerating capacity. Ultimately, it was concluded that slowing of velocity during
shortening in a single SM cell was the result of an internal load that opposes shortening
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and increases as cell length decreases (Harris and Warshaw 1990). Importantly, it was
further concluded that, in the single cell, cell length was disassociated from contractile
element length. In opposition to the sliding filament theory, it was speculated that
stretching a relaxed single smooth muscle cell would not change the position of the
contractile units on the length-force curve. It was proposed that a viscous element may
exist in SM cells that is connected in series with the contractile element thus allowing
changes in cell length to occur without corresponding length changes in the contractile
unit. In the stimulated cell, structural changes could occur to couple the contractile unit
length to cell length. This proposal was the first suggestion of cytoskeletal remodeling
and predicts that stretching (relaxed) smooth muscle would not alter the degree of
myosin–actin overlap, as occurs in SKM (Harris and Warshaw 1991).
Later studies by Gunst et al. (1993) further challenged the sliding filament model
of contraction in smooth muscle. According to the sliding filament model, the amount of
force produced at any length should be a function of the number of crossbridges
contributing to the force production and the rate of shortening should reflect the rate of
crossbridge cycling. It follows that as muscle length increases, force would be increased
but that, given a constant load, shortening velocity should remain constant or increase.
However, it was found that shortening velocity decreases with increasing muscle length
in the single cell. In canine smooth muscle, shortening velocity was higher when the
muscle was stimulated to contract at shorter lengths. The inverse relationship between
velocity of shortening and tissue length at activation was concluded to be the result of
“cytostructural reorganization” of the cell in response to stretch. Such reorganization was
proposed to optimize the contractile force developed at differing lengths, but could also
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create an internal load due to compression of cytoskeletal structure, yielding a system in
which shortening velocity is inversely related to muscle length (Gunst et al. 1993).
Additional studies in canine tracheal smooth muscle focused on changes in force during
oscillations in muscle length (Shen et al. 1997). The surprising finding was that the
active force generated was greatly decreased below isometric force, but returned to this
level upon lengthening. After ruling out other possible cellular mechanisms responsible
for this phenomenon, it was concluded that the decrease in force is due to the plastic
properties of the contractile filaments of smooth muscle cells. During the lapse in force,
the lengths of the contractile elements were proposed to reset in relation to the new cell
length to optimize functionality (Shen et al. 1997). These findings were corroborated by
Battistella-Patterson et al. (1997) by using cytochalasin B, an actin polymerization
inhibitor, to show that the contractile domain of the actin cytoskeleton in aortic rings
could contribute to force development by undergoing remodeling during cell shortening.
This study also suggested that remodeling of actin tension bearing fibers could contribute
to the low energy requirement for tension maintenance by holding the cell in a contracted
state (Battistella-Patterson et al. 1997). It has also been suggested that crosslinking
between actin and intermediate filaments by filamin also contributes to tension
maintenance (Small et al. 1986).
There are several limitations to studying smooth muscle cell structure in tissue.
These include the disordered structure of the differentiated smooth muscle cell
cytoskeleton, the random nature of cell orientation in tissue, as well as extracellular
matrix and connective tissue dynamics. One way of overcoming these complications is
to examine the cytoskeleton of isolated cells from lines that retain the ability to contract
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in culture. One such cell line is the A7r5 embryonic rat aorta cell line. These cells have
been shown to exhibit an adult smooth muscle phenotype, and have retained the ability to
contract (Firulli et al. 1998). The A7r5 cell line was first used in a study by Fultz et al.
(2000) to conclusively demonstrate actin cytoskeletal remodeling during contraction.
Through the use of immunocytochemistry and confocal microscopy, A7r5 cells were
shown to undergo cellular contraction after stimulation with 10-8M phorbol-12, 13dibutyrate (PDBu). Prior to this stimulation both α- and β-actin were localized in stress
fibers that traversed the long axis of the cell. With stimulation, cells underwent cell
constriction characteristic of contraction and both actin isoforms were subject to
structural reorganization. β-actin fibers retained stress fiber formation, but appeared to
shorten during cellular contraction. By comparison the majority of α-actin stress fibers
appeared to reform into dense columns at the periphery of the cell.
Immunocytochemistry revealed that these dense bodies contained not only α-actin, but αactinin (Fultz et al. 2000), an actin crosslinking protein known to localize in dense bodies
of highly differentiated smooth muscle cells in tissue. Dense bodies, identified (Fay and
Delise 1973; Fay et al. 1983) and known to contain α-actinin as early as 1983, are
thought to serve as anchorage points for contractile proteins analogous to the Z line in the
sarcomere of striated muscle. The dichotomy of actin isoform remodeling has led to the
hypothesis that these isoforms serve different functions (Fultz et al. 2000; Li et al. 2001);
β-actin shortens but maintains filamentous structure, holding the cell in the contracted
configuration while α-actin remodels to optimize contractile efficiency and to allow force
development from several foci. It was subsequently determined that the peripheral
bodies reported by Fultz et al. (2000) were podosomes, α-actinin, actin and vinculin-
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containing adhesion structures, likely to function as a molecular scaffold (Hai et al. 2002)
or serve as an analogue of dense bodies (Fultz et al. 2000) in the contracting A7r5 cell.

Podosomes
The term podosome is most often associated with osteoclasts, where they play a
role in bone resorption. They have also been found in macrophages, dendritic cells,
transformed fibroblasts and carcinoma cell lines (Linder and Aepfelbacher 2003). More
recently, podosomes have been identified in leukocytes (Calle et al. 2006), epithelial cells
(Spinardi et al. 2004), endothelial cells (Moreau et al. 2003), and smooth muscle cells
(Gimona et al. 2003; Linder and Aepfelbacher 2003). Although podosome composition
and function can be cell-type specific, most are comprised of an actin core surrounded by
associated proteins and participate in cell adhesion or motility (Linder and Aepfelbacher
2003).
First identified as dynamic actin-containing structures referred to as “dense
bodies,” in A7r5 smooth muscle cells by Fultz et al. (2000), smooth muscle podosomes
have now been recognized as an important component of cytoskeletal remodeling and the
smooth muscle contraction. Besides an actin-rich core, podosomes in this cell type have
consistently been shown to contain α-actinin, an actin-bundling protein, and vinculin, a
focal adhesion-associated protein (Linder and Aepfelbacher 2003). Additionally, A7r5
vascular smooth muscle cell podosomes have been shown to incorporate smooth muscle
myosin (Fultz and Wright 2003), calponin, and PKCα (present study). It should be noted
that A7r5 podosome formation is reported primarily in the isolated cell and is considered
an adaptation necessary for tension development. This reasoning follows the observation
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that very few podosomes are found in cells grown to confluence or in aortic tissue where
multiple cell-to-cell contacts have been formed. These contacts form cell restraints and
provide an anchorage site for actin filaments during contraction. Podosomes therefore
likely play roles in both cellular adhesion and tension generation (Kaverina et al. 2003).
In addition to these functions, smooth muscle podosomes have recently been suggested to
function in extracellular matrix resorption and vascular cell motility (Burgstaller and
Gimona 2005).

Protein Kinase C
Currently there are 12 known isoforms of PKC. Summarized in Figure 4, they are
classified depending upon their requirements for activation. In general, PKC isozymes
possess a regulatory domain and a catalytic domain. The catalytic domain contains the
substrate binding site as well as a phospholipid-binding domain, which allows for
interaction with the plasma membrane. The conventional or classical PKCs have a Ca++binding and a diacylglycerol (DAG)-binding domain, located within their regulatory
domains. Accordingly, these isoforms require phospholipids, Ca++, and DAG (or DAG
analogs like phorbol esters) for activation. Conventional PKCs include the α, βI, βII, and
γ isoforms. Novel PKCs also have a phospholipid-binding domain and a DAG domain,
but lack the Ca++ domain prevalent in conventional forms. Novel PKCs, such as the δ, ε,
η, θ, and µ isoforms, require only phospholipids and DAG for their activation. Atypical
PKCs, including ζ, ι, and λ, do not posses a regulatory domain, and require only
phospholipid binding for activation (Webb et al. 2000).
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Figure 4. Structural domains of PKC isoforms determine their requirements for activation (Newton 1995).

The past decade has seen an upsurge in the study of PKC regulation factors.
Biochemical studies have shown that acidic phospholipids are cofactors for PKC
activation. PKC binding to DAG or phorbol esters in the presence of phospholipids
induces a conformational change in PKC that results in its activation. Similarly, the
presence of free fatty acids lowers the threshold for DAG activation of PKC. PKC is
prone to autophosphorylation and phosphorylation by other serine/threonine kinases and
so is subject to regulation by serine/threonine phosphorylation (Ron and Kazanietz 1999).
Aside from means of stimulation, PKC’s mode of activation is also dependent
upon compartmentalization within the cell, which is achieved through the translocation of
the enzyme to different parts of the cell. It is thought that translocation to the
plasmalemma provides a site where DAG, a PKC activator, is produced. Similarly,
translocations may occur to specialized cellular compartments such as the nucleus, focal
adhesions and other structures containing specific anchoring proteins to localize the
kinase to its site of action. These anchoring proteins can include cytoskeletal elements
and their associated proteins (Webb et al. 2000). Of particular interest to the present
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work, the conventional PKCα has been shown to mediate cytoskeletal remodeling and
podosome formation in A7r5 smooth muscle cells (Hai et al. 2002; Gatesman et al. 2004)
Subsequent portions of this review will discuss PKCα’s interaction with two proteins:
microtubules (β-tubulin) and calponin, an actin-binding protein, molecules now thought
to play an important role in PKCα translocation and PKCα-mediated smooth muscle
contraction, respectively.

The Role of PKC in Smooth Muscle Contraction
PKC is able to exert a variety of effects upon smooth muscle contraction, and is
thought to possess the ability to phosphorylate myosin directly (Sutton and Haeberle
1990) (Figure 2). This action may bypass the need for the Ca++/calmodulin cascade and
represents an alternate pathway for activation of contraction. PKC may also
phosphorylate other elements of the contractile cascade to expedite or modify events in
the process of contraction. For example, PKC is known to activate a 17 kDa protein
designated protein kinase C-dependent phosphatase inhibitor -17, or CPI-17. CPI’s most
notable function is to inhibit myosin phosphatase. Myosin phosphatase serves to
dephosphorylate myosin light chain and without this important “off switch,” myosin will
remain phosphorylated and contraction will continue presumably until the exhaustion of
ATP stores occurs. Hence, PKC-mediated inhibition of myosin phosphatase may serve to
enhance the level of contractile response to a given stimuli in SM. However, under
physiological conditions, activation of contraction utilizes both the Ca++/CaM and PKC
pathways (Figure 5). Binding of norepinephrine at its receptor results in activation of
phospholipase C (PLC), which acts on phosphatidyl-4, 5-bisphosphate (PIP2) to produce
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inositiol-3, 4, 5-triphosphate (IP3) and diacylglycerol (DAG) (Newton 1995). IP3 acts on
calcium channels in the sarcoplasmic reticulum and the sarcolemma to cause the release
of intracellular calcium and enhance the influx of extracellular calcium, respectively.
Hence, the elevation of [Ca++]i results in activation of CaM and may also serve, in
combination with DAG, to precipitate the activation of conventional PKCs.

Figure 5. The role of phosphoinositide hydrolysis in activation of PKC. Phospholipase C (PLC),
activated through a G-protein-coupled receptor, hydrolyzes PIP2 (phosphatidyl-4,5-bisphosphate) into DAG
(diacylglycerol) and IP3 (inositol-3,4,5-triphosphate) (Siegel et al. 1999).
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Protein Kinase C α
Unlike other PKC isoforms, PKCα is ubiquitously expressed and can be activated
in a number of ways. Besides direct activation by Ca++ and DAG analogues, this isotype
can also be activated by cell contact and physical stresses (Nakashima 2002). Regardless
of the stimulus, activation of PKCα requires the translocation from the cytosol to specific
domains within the cell. Li et al. (2002) showed that translocation could be selectively
directed by varying phorbol-12, 13-dibutyrate concentration in the A7r5 cell, suggesting
differential regulation of mechanisms of transport or PKCα tethering at specific sites.
Similar to results obtained by stimulation with the calcium ionophore A23187 or the
intracellular releasing compound thapsigargin, low phorbol concentrations (<10-7M)
promoted PKCα translocation to the plasmalemma. Conversely, higher concentrations of
phorbol (>10-6M) promoted translocation to the perinuclear region of the cell.
Perinuclear translocation could be blocked by microtubular disruption by colchicine, but
plasmalemma translocation was not (Li et al. 2001). Besides showing concentrationdependent responses to a stimulus, the fact that one of these responses could be
selectively inhibited demonstrated the likelihood that PKCα is translocated by different
pathways.
PKCα has also been found to mediate the formation of podosomes (Hai et al.
2002; Gatesman et al. 2004) in the contracting A7r5 SM cell. As noted earlier, podosome
formation is a hallmark of cytoskeletal remodeling in the contracting A7r5 SM cell. This
remodeling was attributed to the α isoform based on several observations. First, PKCα is
the predominant conventional PKC isoform in this cell type. Secondly, podosome
formation was induced by the addition of 1µM PDBu, a known DAG analogue and
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conventional PKC activator. In addition, cytoskeletal remodeling and podosome
formation was blocked by treatment with GÖ6976, a PKC inhibitor known to be highly
selective for PKCα and to have no effect on other PKC classes (Hai et al. 2002).

Microtubules
The term microtubule refers to tubules formed from a mixture of α- and β-tubulin
and microtubule-associated proteins (MAPs). α- and β-tubulin monomers pair to form
dimers, from which a polar protofilament is formed. Subsequently, thirteen such
protofilaments join in parallel to form a polar, hollow tube. Microtubules exhibit polarity
with distinct ends: a fast-growing plus end and slow-growing minus end. Both α- and βtubulin bind guanosine triphosphate (GTP). However, only β-tubulin can hydrolyze this
molecule to guanosine diphosphate (GDP) (Kreis and Vale 1999). This hydrolysis
weakens β-tubulin’s binding affinity for other molecules and therefore results in
depolymerization of the filament. Tubulin molecules on the minus end of the filament
are continually lost while tubulin bound to GTP is continually added to the plus end.
This is the basis for the phenomenon known as treadmilling (Margolis and Wilson 1998).
The drug colchicine blocks microtubule polymerization, while another drug, taxol, blocks
depolymerization and thus stabilizes the filament. Both drugs are classified as antimitotic agents and are used as anti-cancer agents directed at rapidly growing cells
(Margolis and Wilson 1998).
Microtubules originate near the center of a cell at the centriole and project radially
toward the periphery. Extending through the cell in this manner enables these filaments
to serve a variety of functions in the organization of the cell. Positioning of membrane-
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bound organelles is dependent upon microtubular configuration (Duden et al. 1990).
Additionally, this radial arrangement is ideal for another microtubule function, that of
intracellular transport. Cytoplasmic microtubules associate with two families of motor
proteins that shuttle cell components within the cell. The kinesins move toward the plus
end of the filament (periphery of the cell), while the dyneins move toward the minus end
at the center of the cell. Both kinesins and dyneins have globular heads with ATPhydrolyzing activity. Hydrolyzing ATP to ADP provides the energy for a cycle of
conformational changes that enable the molecule to move along the tubule. The tails of
these proteins bind to certain cellular components or organelles and transport them in this
manner (Sheetz 1999). Besides anchoring to cell components via motor proteins, tubulin
has also been shown to bind directly to other key proteins, such as phosphofructokinase,
glyceraldehyde-3-phosphate, phosphatidyl inositol-3-kinase (PI-3K) (Janmey 1998), actin
(Sider et al. 1999), and PKCα (Schmalz et al. 1996). These associations provide the basis
for a signaling role for microtubule proteins, although this proposed role of microtubules
has not been widely studied.
There is also evidence to suggest that the microtubular system plays an indirect
role in the contraction of excitable cells. When microtubules in non-muscle cells
(fibroblasts, endothelial cells) are disrupted by treatment with an anti-mitotic agent such
as colchicine, there is an increase in contractility. Similarly, several studies have
described a colchicine-mediated increase in force in intact arteries (Paul et al. 2000). The
work of Battistella-Patterson et al. (1997) showed that colchicine-induced microtubule
disruption produced an increase in force in the initial fast phase of tension development,
but caused a reduction in force and a delay in development of the secondary, slow phase
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of tension development. Ingber (1993) proposed a theory explaining this phenomenon.
Cellular tensegrity is a model in which microtubules are postulated to function as rigid
struts that oppose the force generated by myosin. Disruption of this resistive force with
the drug colchicine is predicted to allow a greater degree of the force generated by the
actin-myosin contraction to be transmitted throughout the cell, thus augmenting the
contraction (Paul et al. 2000).

Calponin
Calponin (CaP) is a 34kDa actin-binding protein first isolated from chicken
gizzard by Takahashi et al. (1986). To date, four isoforms have been described. Basic or
h1 calponin is most well characterized and is known to be SM specific. Calponin β is a
product of alternative splicing from the h1 calponin gene. Neutral or h2 calponin and
acidic calponin are expressed in non-muscle cells, as well as SM (Winder et al. 1998). h1
Calponin has been shown to bind to α-actin (Takhashi et al. 1986), β-actin (Szymanski
2004), HSP27, PKCα (Patil et al. 2004), tubulin, desmin, myosin (Szymanski 2004), and
other proteins through its versatile calponin homology (CH) domains and several proteinspecific binding sites (Czurylo et al. 2000). This characteristic of CaP is suggestive of
the wide utility of this multifunctional protein.
Calponin’s most prominent role is regulated by PKCα. In the resting SM cell,
calponin has a high binding affinity for filamentous actin. This binding prevents actin
from interacting with the myosin head, and thus prevents cellular contraction. With
cellular stimulation, PKCα is also activated and is able to translocate to and
phosphorylate calponin. This phosphorylation induces a conformation change in
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calponin, causing it to release actin which is then free to interact with myosin and the
contraction can proceed. As shown in Figure 3, this disinhibition can be reversed by
protein phosphatase 2A (PP2A) (Winder and Walsh 1990).
The ability to crosslink actin and to bind other cytoskeletal proteins has led to
calponin’s implication in cytoskeletal organization and actin stabilization. Based on
several pieces of evidence, calponin may also have a signaling function. Namely, the
calponin homology domain is homologous to those found in several signaling molecules.
More promising proof stems from the fact that calponin has been found to be a direct
target for Rho-associated kinase (ROCK) (Kaneko et al. 2000), a serine/threonine kinase
involved in SM contraction . Additionally, Leinweber et al. (1999) have shown direct
interaction between the CH (calponin homology) domain of calponin and the MAP
kinase signaling molecules ERK1 and ERK2 (Leinweber et al. 1999).

Atomic Force Microscopy
Gerd Binnig received the Nobel Prize in 1986 for his work in scanning probe
microscopy and is credited with inventing the atomic force microscope (AFM). The
AFM is a topographic instrument, used for studying surface properties of materials. A
sensitive technique, AFM can reach atomic level resolution. An AFM consists of a tiny
tip, usually only 2-3µm in length, suspended from a cantilever (Figure 6). The cantilever
is best described as a diving board. Only 100 to 200µm long, the cantilever bends as the
tip comes in contact with attractive and repulsive forces on the surface of the sample.
These cantilever deflections can be measured as a laser signal is reflected off the back of
the cantilever and onto a split photo-diode, divided into four quadrants, A, B, C, and D.
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By measuring the differences in signal between these quadrants, the cantilever’s position
can be measured. (Dykes 2001).

Figure 6. Depiction of AFM components: cantilever, tip, laser deflection, and split photo-diode.
Taken from www.molec.com/apps_ imagingmodes.html.

AFM scanning is typically performed in one of three modes: contact, non-contact,
or intermittent. Contact AFM, also known as repulsive mode, occurs when the tip
actually makes soft contact with the sample. As the tip rasters over the sample the
contact force causes the cantilever to bend with changes in topography. This mode is not
recommended for biological samples since even slight contact may damage the sample.
Non-contact AFM is a technique where the cantilever vibrates near the surface of the
sample (within angstroms). This mode is ideal for imaging soft samples. The lack of
physical contact ensures the avoidance of sample degradation. However, the presence of
liquid will distort the resulting image by imaging the surface of the liquid layer rather
than the surface of the sample itself. Therefore imaging within a fluid cell, as for live
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imaging, cannot be performed in this mode. The third AFM mode incorporates elements
of both contact and non-contact AFM. Intermittent-contact mode operates like noncontact AFM in that the cantilever vibrates near the sample surface. However, in this
mode, also called “tapping mode” the cantilever is so near the sample that the tip will
barely hit or “tap” the surface. An image is produced by monitoring the tip’s oscillating
amplitude changes in response to the distance between the tip and the sample. Tapping
mode is the most commonly used since it overcomes the limitations of both contact and
non-contact imaging. Due to the reduced physical contact, there is less sample damage
than contact AFM, and tapping mode gives better resolution of large samples than noncontact because of the decreased tip-to-sample distance (Howland and Benatar 1993).
AFM has proven to be a great tool in the biological sciences and offers several
advantages over previously employed methods of studying biological tissue, enabling for
the first time the imaging of the three-dimensional surface structure of biological
specimens. Also, samples can be imaged in a fluid cell, so physiological processes can
be viewed in real time at molecular resolution. Although earlier methods, such as
electron microscopy (EM) and X-ray diffraction could offer molecular resolution,
extensive sample preparation was a drawback. Besides prolonging an experiment, these
methods call for sample dehydration, fixation and/or embedding. All are harsh to
delicate tissues and may alter the native configuration of the sample. Importantly,
samples can not be studied live under these conditions (Lal and John 1994).
Basic AFM operation can be modified to reveal even more information about a
sample. For example, the viscoelastic properties of several biological materials have
been reported. Radmacher et al. (1992) imaged elasticity and viscosity of platelets. Lal
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and John (1994) proposed the study of localized viscoelastic properties of molecular
motors during muscle contraction. In other studies, the morphological changes of
cultured glial cells have been recorded and AFM was used to observe the growth of the
cell edge and the widening of space between filamentous structures (Henderson et al.
1992). More recently, the real-time contractility of cultured atrial myocytes was
observed. As ionotrophic calcium was increased, the cells underwent rapid contraction
and a shortening of cytoplasmic fibers. Additionally, it was predicted that the force
sensitivity of AFM could be used to obtain direct information about localized lengthtension relationships in a contracting cell (Lal and John 1994).

Fluorescence Resonance Energy Transfer
Fluorescence resonance energy transfer (FRET) has been described as a distancedependent interaction between two fluorescent molecules in which the stimulated
emission of one molecule, the donor, is transferred to a second, acceptor molecule, where
it serves as excitation energy and results in emission at a longer wavelength (Haugland
2002) (Figure 7). In a conventional fluorescent system, light excites a fluorescent
molecule at its characteristic excitation wavelength. When the molecule becomes
“excited,” one of the molecule’s electrons is promoted to a higher energy level, and the
molecule is said to be in an electronic excited state. The electron quickly decays to a
lower vibrational level, and then more slowly decays back to the ground state as a photon
of light is emitted. The wavelength of the emitted photon is longer than the excitation
wavelength. Within a FRET system, the donor molecule is excited in this way.
However, when FRET occurs, a photon is not emitted from the donor. Instead that
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energy resonates, or is transferred, to the neighboring acceptor fluorophore and is able to
repeat this excitation process in the new molecule. The resulting photon of light will be
of a wavelength longer than the excitation wavelength of the donor or the acceptor
(Haugland 2002).
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Figure 7. Example of FRET process. Modified from meds.queensu.ca/ qcri/greer/ri_pag.htm.

There are three primary conditions that must be met in order for FRET to occur.
Foremost, the donor and acceptor pair must be in close proximity. Specifically, they
must be close enough for the described energy transfer to occur. For most donoracceptor pairs this distance falls between 10 and 100 Å. Another characteristic of the
donor-acceptor pair is the Förster radius, R0 (Figure 8.) When transfer efficiency is
plotted as a function of the distance between the donor and acceptor, the Förster distance
is defined as the distance between fluorophores at which energy transfer is 50%.
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Figure 8. The Förster distance is defined as the distance between two fluorophores at which a
50% efficiency of energy transfer occurs (Haugland 2002).

A second requirement is illustrated in Figure 9. Here, the excitation spectrum of the
acceptor overlaps the emission spectrum of the donor. According to the FRET process
described above, this physical trait is essential for observing the secondary acceptor
emission (Haugland 2002). The third and final requirement for FRET to occur involves
the fluorophores’ transition dipole orientations. This orientation factor, denoted as κ, is
simply a measure of the angle between the two fluorophores. Efficiency of energy
transfer is most efficient when the fluorophores’ orientations are approximately parallel,
as shown in Figure 10. Because this is a dipolar system, κ2 is directly proportional to R6,
the sixth power of the distance between the two fluorophores (probability of energy
transfer α κ2 / R6). κ can vary between 0 and 4, but when orientation cannot be
determined it is assigned a value of 2/3 for randomly oriented donors and acceptors.
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Figure 9. Spectral overlap of a donor fluorophore (Alexa 488) and an acceptor fluorophore (Alexa 546)
(Haugland 2002).

Figure 10. Depiction of parallel dipole orientations, denoted κ2. Red arrows indicate electronic field (Fish
2005).
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The FRET phenomenon was first described by T. Förster (Forster 1948). Known as
Förster’s theory of resonance transfer, this first paper illustrates how the probability of
resonance depends on the local configuration of fluorophores (Stephens 2006). From
quantum mechanics it can be shown, as mentioned above, that the energy transfer
efficiency (E) varies inversely with the sixth power of the distance between the donor and
the acceptor:
E = 1 / [r / R0)6]
where r is the distance between the donor and the acceptor (Stephens 2006). In some
cases, these calculations can not be ciphered directly and the energy transfer efficiency
must first be determined experimentally. If FRET conditions are met, the result will be a
quenching of donor fluorescence accompanied by an increase in acceptor fluorescence.
In acceptor photobleaching FRET, donor quenching is measured by the extent of
“dequenching” after acceptor photobleaching. The increase in donor fluorescence is used
to calculate the energy transfer efficiency using the equation:
E = 1 – ID /IDNA,
where ID is the intensity of the donor in the presence of the acceptor and IDNA is the
intensity of the donor with no acceptor (Kenworthy 2001; Stephens 2006).
Giving spatial resolution beyond the scope of conventional light microscopy, the
sensitivity of FRET has allowed for the advancement of basic science research in several
fields. Examples of FRET applications now in common use include the study of protein
structure, spatial distribution of proteins, immunoassays, real-time PCR (polymerase
chain reaction), and membrane fusion assays (Haugland 2002). More specifically, FRET
has enabled greater understanding of the SM contraction process. The distance between
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actin and myosin was measured long ago (dos Remedios et al. 1987). Since then, FRET
has been used for Ca++-imaging (Truong et al. 2001) and contractile protein localization
in cell and tissue studies (Black et al. 2006). In addition, this sensitive technique was
used to analyze conformational changes in the myosin head during ATP hydrolysis
(Mizukura and Maruta 2002).
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Abstract

Utilizing laser scanning confocal, fluorescence resonance energy transfer (FRET), and
atomic force (AFM) microscopy, we have investigated the association of PKCα with
microtubules during stimulus-induced relocalization in A7r5 smooth muscle cells.
Confocal microscopy using standard immunostaining techniques confirmed earlier
observations that colchicine disruption of microtubules blocked PKCα localization in the
peri-nuclear region of the cell caused by phorbol-12, 13-dibutyrate (PDBu, 10-6M).
Dual-immunostaining suggested co-localization of PKCα and β-tubulin in both
unstimulated and PDBu-treated cells. This finding was verified by FRET microscopy
which indicated that the association of PKCα was heterogeneous in distribution and
confined primarily to microtubules in the peri-nuclear region. FRET analysis further
showed that the association between the molecules was not lost during colchicineinduced dissolution of microtubules, suggesting the formation of tubulin/PKCα
complexes in the cytosol. Confocal imaging indicated that peri-nuclear microtubular
structure was more highly sensitive to colchicine dissolution compared to other regions of
the cell. Topographical imaging of fixed cells by AFM indicated a well-defined elevated
structure surrounding the nucleus which was absent in colchicine-treated cells. It was
calculated that the volume of the nuclear sleeve-like structure of microtubules increased
approximately 5-fold in PDBu-treated cells, suggesting a probable increase in
microtubular mass. Based on PKCα localization, increased colchicine sensitivity, and
their volume change in stimulated cells, the results suggest that peri-nuclear microtubules
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form a specialized structure which may be more dynamically robust than in other regions
of the cell. PKCα could contribute to this dynamic activity. Alternatively, peri-nuclear
microtubules could act as a scaffold for regulatory molecule interaction at the cell center.

Key Words: cytoskeleton, microtubules, PKCα, translocation, A7r5
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Introduction
The protein kinase C (PKC) family consists of a group of serine-threonine kinases
separated into three subgroups based on their structure and activation requirements. Cells
are commonly found to express several PKC isoforms (4) and PKC may be involved in
the regulation of multiple cell functions within a single cell type. This suggests that
individual isoforms phosphorylate specific substrate(s) and that compartmentalization of
isoform activity occurs under physiological conditions (19). One way this is thought to
occur is through translocation to isoform-specific sites located adjacent to target
substrate. The inactive form of PKC is diffusely distributed throughout the cytosol or
may be localized to specific regions or structures in the cell. Following stimulation of the
cell, isoforms may relocate from inactive pools to their active cell loci. Hence, the
intracellular translocation of PKC may represent an important mechanism for targeting
specific substrates and control of isoform function.

There is evidence that the translocation of an individual PKC isoform may be varied in a
single cell type through use of different stimulatory agents (18), whether highly
differentiated (14, 10, 7) or less highly differentiated passaged cells (1) are utilized, and
depending on cell culture conditions (8). In addition, our laboratory has reported that
PKCα may be selectively relocated at the plasmalemma or the peri-nucleus of A7r5
smooth muscle cells, depending on the concentration of phorbol ester (16). The A7r5
clonal cell line was chosen for these studies because it exhibits an adult smooth muscle
phenotype (5). This cell line was originally derived from embryonic rat aortic smooth
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muscle (15) and shows expression and promoter activity of several highly restricted
smooth muscle cell markers (5). In addition to these indications of smooth muscle
phenotype, A7r5 cells retain the ability to contract by both Ca+2-dependent and independent mechanisms (20, 6, 17) which is lost in passaged smooth muscle cells.
Interestingly, our studies with A7r5 cells indicated that translocation of PKCα to the perinucleus but not the subplasmalemma was blocked by the use of colchicine to disrupt cell
microtubules (16). These studies indicated that concentrations of PDBu at or below
10-7M resulted in colchicine-insensitive translocation of PKCα to the subplasmalemma,
whereas PDBu concentrations above 10-7M caused colchicine-sensitive relocation of the
enzyme in the peri-nuclear region. By comparison, concentrations of PDBu ranging from
10-9M to 10-5M resulted only in colchicine-sensitive translocation of PKCα to the perinuclear region of multi-passaged cells derived from rat aortic smooth muscle (1). These
observations suggest that in the highly proliferative, dedifferentiated passaged smooth
muscle cells, only the colchicine-sensitive mechanism for peri-nuclear translocation of
PKCα is operative or sensitive to PDBu activation, whereas high concentrations of PDBu
are required to unmask this mechanism in A7r5 cells. Hence, it was concluded that
multiple pathways are available for the redistribution of active PKCα in A7r5 cells which
could utilize different mechanisms for the movement or docking of the isoform at
specific target sites. However, due primarily to interference from the intensity of PKCα
immunostaining, this early study was unable to show clear evidence for a direct
association of PKCα with microtubules. Hence the role of the microtubular cytoskeleton
on PKCα localization at the peri-nucleus following phorbol ester stimulation remained
unclear.

38

In the present study, we investigated the association of PKCα with microtubular structure
in A7r5 smooth muscle cells stimulated with 10-6M PDBu, the concentration previously
demonstrated to cause colchicine-sensitive PKCα translocation to the peri-nucleus. The
results confirm earlier observations that peri-nuclear translocation of PKCα requires an
intact microtubular cytoskeleton. The results further indicate at least a partial association
of PKCα with microtubules in the unstimulated and PDBu-stimulated cell.
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Materials and Methods
Cell culture
A7r5 cells, originally derived from embryonic rat aorta and exhibiting an adult smooth
muscle phenotype (5) were obtained from American Type Culture Collection (Manassas,
VA) and cultured in Dulbecco’s modified Eagle’s medium (DMEM) that was
supplemented with 10% fetal bovine serum, 100 units/ml penicillin G, and 100µg/ml
streptomycin. Cells were plated onto 75cm2 culture flasks and grown to approximately
85% confluence. Cultures were maintained at 37°C in a humidified atmosphere of 5%
CO2 in air. The medium was changed every two days and the cells were passaged at least
once a week. Cells were detached from the culture flask by the addition of a 1:10
0.5%/5.3mM trypsin/EDTA solution in phosphate-buffered saline (PBS).

Cell plating and treatment
A7r5 cells were plated onto 22mm by 22mm #1 glass coverslips placed in six well
culture plates and returned to the incubator for a minimum of 24 hours to allow for cell
attachment and spreading. Cells were treated prior to fixation according to one of five
protocols: (1) control cells received vehicle but no treatment before fixation; (2) PDBu
cells were treated with 10-6M phorbol-12, 13-dibutyrate (PDBu) (Sigma Chemical Co.,
St. Louis, MO) for up to 30 minutes; (3) control/colchicine cells were treated with
40µg/ml colchicine (Sigma Chemical Co., St. Louis, MO) for 30 minutes; (4)
PDBu/colchicine cells were treated with 10-6 M PDBu for 30 minutes followed by
treatment with 40µg/ml colchicine for 30 minutes; and (5) colchicine/PDBu cells were

40

treated with 40µg/ml colchicine for 30 minutes followed by treatment with 10-6 M PDBu
for 30 minutes. Cells were fixed and permeabilized by the addition of ice-cold acetone
for 1 minute. Fixed cells were preserved in 1X PBS buffer.

Confocal and FRET microscopy
In preparation for experiments using laser scanning confocal microscopy, A7r5 cells were
plated and fixed as previously described. Following fixation the cells were washed
multiple times (3X) with PBS containing 0.5% TWEEN-20 (PBS-T), pH 7.5, and
incubated for 30 minutes in a blocking solution (5% nonfat dry milk in PBS). Cells were
stained for β-tubulin by incubation in a 1:500 dilution of monoclonal anti-β-tubulin clone
TUB 2.1 FITC-labeled antibody (Sigma Chemical Co., St. Louis, MO) for a minimum of
2 hours at room temperature. For α-actin staining, fixed cells were incubated with a
1:500 dilution of monoclonal anti-α-smooth muscle actin clone 1A4 FITC-labeled
antibody (Sigma Chemical Co., St. Louis, MO) for 30 minutes at room temperature. For
total F-actin staining, cells were incubated with 2.5 x 10-6M TRITC-labeled phalloidin
(Sigma Chemical Co., St. Louis, MO) for 30 minutes at room temperature. Cells were
stained for vimentin via incubation with a 1:300 dilution of monoclonal anti-vimentin
clone V9 (Sigma Chemical Co., St. Louis, MO) at room temperature for 2 hours. Fixed
cells were stained for PKCα using a 1:500 dilution of anti-PKCα-clone M4 (Upstate
Biotechnology, Lake Placid, NY). Treatment with anti-vimentin and anti-PKCα
solutions was followed by the addition of Alexa Fluor 488-labeled secondary antibody
(Molecular Probes, Inc., Eugene, OR). In studies utilizing fluorescence resonance energy
transfer (FRET) microscopy, Alexa Fluor 546 (Molecular Probes, Inc., Eugene, OR) was
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employed as the secondary antibody to anti-PKCα.

Stained cells were surveyed by mounting on a Nikon Diaphot Microscope. Confocal
microscopy was performed with a BioRad Model 1024 Scanning system equipped with a
krypton/argon laser. Cells stained with Alex Fluor 488 or FITC conjugates were excited
with the 488nm laser line at 10% power. The resulting emission was visualized using a
522 DF 32 band pass filter. For colocalization studies, the BioRad Scanning system’s
multichannel capacity was engaged. When both an FITC conjugate and Alexa Fluor 594
were present, a HQ 598/40 band pass filter was used to observe the secondary
fluorophore simultaneously on a second channel. Similarly, multiple channels were
necessary in FRET microscopy. Within a FRET system two fluorophores with
overlapping emission and excitation spectra are implemented. Here FITC (excitation,
488nm; emission, 520 nm) and Alexa Fluor 546 (excitation, 546nm; emission, 580nm)
were the donor/acceptor pair employed. The donor molecule (FITC) was directly excited
and the resulting emission is visualized using the 522 DF 32 band pass filter. However, a
portion of energy given off by the fluorophore is not released as light but is transferred to
a neighboring fluorophore that can be excited at that wavelength. Thus the FITC
emission induced the Alexa Fluor 546 molecule to release energy as light at its
characteristic emission wavelength which was visualized on a second channel using an
HQ 598/40 band pass filter. The resonance energy transfer can only occur if the
donor/acceptor molecules are close enough to each other for the transfer to occur
efficiently. The Förster distance (R0) is the distance at which fluorescence resonance
energy transfer from the donor dye to the acceptor dye is 50%. Distances greater than R0
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will result in less intense emission while distances less than R0 will yield higher
intensities. The Förster distance calculated for this pair is 64 angstroms. Resultant
images were analyzed using Lasersharp and Confocal Assistant software (BioRad,
Hercules, CA).

In order to calculate the distance between PKCα and β-tubulin, images of cells were
acquired using laser scanning confocal microscopy with excitation at the 488nm-laser
line. To obtain an internal control, the imaging area was then excited at the 568nm-laser
line at 100% power to photo-bleach the acceptor molecule (PKCα). Subsequently, a
second set of images was acquired again using 488nm-laser line excitation and the
appropriate multi-channel filter set to measure β-tubulin FITC emission (522 DF 32) and
to verify the absence of anti-PKCα secondary antibody Alexa 546 emission (HQ598/40).
The images were analyzed by two methods; both the determination of whole cell
emission intensity and by a single line scan emission intensity measurement. By
selecting the entire scan area, an intensity profile was generated for each whole cell
image (Image J Software, NIH) with the resulting plot analyzed using Peakfit v4.11
software (SPSS Science, Inc., Chicago, IL) to obtain the area under the curve. These
values were then utilized in calculating the efficiency of energy transfer (E) and the
distance between the donor and acceptor pair (r) using the equations below (a, b) (13)
where: ID is the intensity of the donor molecule in the presence of acceptor molecule;
IDNA is the intensity of the donor molecule in the absence of acceptor (after photobleaching); r is the FRET distance between donor and acceptor molecules; and Ro is the
Förster distance
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a)

E = 1 - ID/IDNA

b)

E = 1/[1 + (r/R0)6].

The resulting distances were analyzed by Sigma Stat 2.03 (SPSS Inc., Chicago, IL) in
comparisons of values obtained for control cells, those stimulated with PDBu, and
colchicine-treated cells. Images analyzed by line scan emission intensity were also
evaluated using Image J (NIH). For each set of images (ID, before photo-bleaching; IDNA,
after photo-bleaching), a line was arbitrarily drawn to bisect the cell nucleus and
extending to the visible peripheral borders of the cell. The resulting plot profile was then
utilized to evaluate two aspects of the intracellular regional distribution of the association
between β-tubulin and PKCα. Initially we compared the FRET distance in the
perinuclear versus the peripheral region of the cell. This was accomplished by averaging
the two highest values within the twenty pixel distance of the nuclear mass and the cell
peripheral border. Secondly, we identified the point of maximum efficiency of energy
transfer (E) on the line scan as a focal area in which PKCα interaction with tubulin might
approach saturating conditions

Atomic Force Microscopy
In experiments employing atomic force microscopy (AFM) fixed cells were rinsed with
deionized water and dried with compressed air prior to study. Coverslips were mounted
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to 20mm AFM metal specimen discs (TMMicroscopes, Sunnyvale, CA) using 12mm
carbon conductive tabs (Ted Pella, Inc., Redding, CA). Cells were imaged in contact
mode using a TMMicroscopes Explorer atomic force microscope (2). All images were
acquired with either TMMicroscopes Model No. 1520-00 or Model No. 1930-00
cantilevers. Subsequent analysis of images was performed using SPMLab version 5.01
analysis software (TMMicroscopes, Sunnyvale, CA). Based on the whole cell scan of
each cell a line scan was performed bisecting the nucleus in an axis arbitrarily chosen to
provide measurement outside the visible perimeter of the cell. The reference point for
each cell height measurement was the default point assigned as zero by the SPM Lab
Analysis software. Because the height of the nuclear sleeve was the object of study, and
to avoid sampling bias, the measurement of cell height (untreated) or ground substance
(colchicine-treated) was obtained by using the whole cell scan to visually set
measurement points on the sleeve rim or immediately adjacent to the nuclear mass, which
were then identified for analysis on the line scan. The two measurements on opposite
sides of the nucleus were then averaged to give a single value for height.

AFM measurements showed a well-defined, elevated structure surrounding the nucleus
(Figs 9, 11) that was absent in colchicine-treated cells (Fig. 10, 12). Based on these
observations it was concluded that the central network of microtubules formed a sleevelike structure surrounding the nucleus. The sleeve diameter and thickness were directly
measured and sleeve height was obtained by subtracting the average cell height of
colchicine-treated cells (ground substance) from the cell height of individual untreated
cells (Fig. 13). Based on these measurements the average volume (V) of the microtubular
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sleeve was then determined using the formula for calculation of the volume of a hollow
cylinder indicated below, where; V is the volume of the microtubular sleeve, h is the
sleeve height, r0 is the outside radius, and rι is the inside radius of the cylinder.
V= h x πr02 - h x πrι2

Statistics
Differences in FRET distances and AFM obtained topographical measurements were
analyzed by one- or two-way ANOVA followed by Student’s t-test (Sigma Stat 2.03,
SPSS Science, Inc., Chicago, IL). Differences were considered significant if p<0.05 in
all cases. The data are presented as mean ± SEM throughout the text.
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Results

Previous work (16) has indicated that stimulation of A7r5 cells with PDBu (>10-7M)
results in the peri-nuclear translocation of PKCα with evidence that this movement is
blocked by treatment with colchicine. PKCα appears to be diffusely distributed in the
unstimulated cell (Fig. 1a). However, the addition of 10-6M PDBu resulted in intense
staining for PKCα in the peri-nuclear/nuclear region of the cell (Fig. 1b). Addition of
colchicine (40µg ml-1) prior to PDBu blocked the translocation of PKCα (Fig. 1c), while
its addition to the media after stimulation with PDBu caused a punctate, diffuse
redistribution of PKCα back into the cytosol (Fig. 1d). These results suggest that
activated PKCα is associated in some fashion with peri-nuclear microtubules or other
microtubule-dependent cell structure.

Figure 2 shows the structural distribution of the microtubular (β-tubulin), actin (α-actin,
phalloidin) and intermediate filament (vimentin) components of the cytoskeleton in
unstimulated (control) and PDBu-activated A7r5 cells. Unlike the distribution of actin
filaments, the dense network of microtubular and intermediate filament structure
surrounding the nucleus provided an early suggestion of these two filament types as
candidates for a role in PKCα localization. Dual-immunostaining suggested a significant
degree of co-localization of microtubules and PKCα in both control and PDBustimulated cells but particularly in perinuclear region of the PDBu-treated cells (Fig. 3).
The conclusion of tubulin/PKCα interaction was strengthened by FRET microscopic
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evaluation of whole cell scans which indicated an association between microtubules and
PKCα in both stimulated and unstimulated cells as well as colchicine-treated control and
PDBu-stimulated cells (Fig. 4). These images further suggested that the tubulin/PKCα
association was largely confined to the central region of cells having an intact
microtubular system.

Consistent with results from whole cell emission scans, FRET analysis of line scans from
control (Fig. 5) and PDBu-stimulated (Fig. 6) cells indicated a heterogeneous distribution
of tubulin/PKCα association with evidence of high levels in the efficiency of energy
transfer (E) in the peri-nuclear region compared to that at the periphery of the cell.

The calculation of FRET distances from whole cell emission scans yielded similar values
among control, PDBu-stimulated, and colchicine-treated groups (Table 1) supporting the
conclusion of significant tubulin/PKCα association in cells both before and after
disruption of microtubular structure. Further, FRET distances were significantly
increased in the periphery compared to the peri-nucleus in both control and PDBustimulated cells, verifying visual observations of differences in the regional distribution
of tubulin/PKCα interaction within the cell. Interestingly, the FRET distances calculated
for points of peak efficiency of energy transfer (E) obtained from each line scan (Table 1)
were very similar among the different groups (60.1 ± 0.4 Å) and fell at the upper end of
the range of measurements reported between known loci on actin and myosin (22).
These latter findings further suggest the occurrence of discrete “hot spots” of
tubulin/PKCα interaction within the cell.
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Because colchicine caused dispersal of PKCα from the peri-nuclear region in cells
preactivated with PDBu (Fig. 1), it was of interest to evaluate the effect of the drug on the
major cytoskeletal elements. Colchicine treatment had no detectable effect on actin
microfilaments or on intermediate filaments (Fig. 7), greatly reducing the likelihood of
their involvement in PKCα localization. By comparison, the drug caused the complete
disruption of all but the very peripheral microtubular structure within 20 min. after
addition to the medium (Fig. 8). Interestingly, the colchicine-induced dissolution of
microtubules was clearly observed to occur at variable rates in different regions of the
cell. The organization of microtubules was consistent among the great majority of A7r5
cells imaged, forming a dense network about the nucleus from which cables of
microtubules radiated to a second dense network at the subplasmalemma. Upon
treatment with colchicine, we invariably noted initial dissolution of the central network,
which was generally complete before loss in the structural integrity of radiating cables or
peripheral structure was noticeable.

Topographical imaging of fixed cells by AFM revealed a well-defined, elevated structure
surrounding the nucleus (Fig. 9), which was absent following treatment with colchicine
(Fig. 10). A similar analysis of the PDBu-activated cell (Fig. 11, 12) indicated that the
contraction of the cell significantly altered the dimensions and increased the volume of
this structure by roughly 5-fold (Fig. 13). The results suggest that the dense network of
microtubules at the center of the cell forms a sleeve-like structure which, based on
enhanced sensitivity to colchicine and the regional association with PKCα, may represent
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a more dynamic and specialized subgroup of microtubules. The significant change in the
dimensions and volume of the microtubular sleeve could reflect compression of the
structure during cell contraction or an artifact of sample preparation. Alternatively, these
results could be suggesting active polymerization and an increase of microtubular
structure in the central region of the activated A7r5 cell.
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Figure 1.

Effect of colchicine on the translocation of PKCα in A7r5 smooth muscle
cells. PKCα appeared diffusely distributed throughout the cell prior to
stimulation (a). Within 30 minutes after the addition of phorbol 12, 13
dibutyrate (PDBu, 10-6M), PKCα translocated to the peri-nuclear region of
the cell (b). The addition of colchicine (40µg/ml) to the medium 20 minutes
prior to PDBu blocked PKCα translocation (c). The addition of colchicine
30 minutes after PDBu resulted in the dispersal of PKCα from the perinuclear region back into the cytosol (d). Cells were fixed with acetone and
stained with anti-PKCα clone M4 primary antibody followed by Alexa 488labeled secondary antibody prior to confocal imaging. Images represent
those obtained in 3 individual experiments in which a total in excess of 120
cells were evaluated from each treatment group.
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Figure 2.

Confocal images showing microtubular (β-tubulin), microfilament (α-actin,
phalloidin), and intermediate filament (vimentin) cytoskeletal structure in
unstimulated (control) and PDBu-activated A7r5 smooth muscle cells.
Microtubules were visualized using a monoclonal anti-β-tubulin clone
TUB2.1 FITC-labeled antibody. Actin was visualized by use of a
monoclonal anti-α-smooth muscle actin clone 1A4 FITC-labeled antibody
or TRITC-labeled phalloidin. Intermediate filaments were imaged through
use of a monoclonal anti-vimentin clone V9 primary antibody followed by
Alexa 488-labeled secondary antibody. Images are representative of those
obtained in 3 individual experiments in which a total in excess of 120 cells
were evaluated in each group.
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Figure 3.

Dual immunostaining of microtubules and PKCα in unstimulated (control)
and PDBu-activated A7r5 cells. Thirty minutes following the addition of
PDBu (10-6M) to the medium cells were fixed with acetone and prepared for
confocal imaging. Microtubules were visualized using a monoclonal anti-βtubulin clone TUB2.1 FITC-labeled antibody. PKCα was visualized by
staining with monoclonal anti-PKCα clone M4 primary antibody followed
by Alexa 594-labeled secondary antibody. Yellow color indicates colocalization of the two proteins. Images shown are exemplary examples of
those obtained in 4 individual experiments in which a total of 173 cells were
evaluated.
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Figure 4.

Evaluation of microtubule and PKCα co-localization by fluorescence
resonance energy transfer (FRET) microscopy in unstimulated (Control),
PDBu-activated, and colchicine-treated A7r5 cells. Cells received vehicle
or 10-6M PDBu for 30 minutes and were fixed with acetone for FRET
imaging. Colchicine (40µg/ml) was added to the medium 30 minutes after
the injection of PDBu. Cells were stained for β-tubulin using monoclonal
anti-β-tubulin clone TUB2.1 FITC-labeled antibody and for PKCα using
monoclonal anti-PKCα clone M4 primary antibody followed by Alexa 546labeled secondary antibody. The FRET effect was observed by excitation at
488 nm only. At this wavelength FITC (β-tubulin) was directly excited to
fluoresce, with emission capture at 522nm. The excitation of Alexa 546
(emission capture at 598nm) and PKCα visualization therefore indicates
protein-protein interaction. Images represent those obtained in 4 or 5
individual experiments in which a total of 15 cells were evaluated.
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Figure 5.

Line scan analysis showing β-tubulin emission intensity before (A, a) and
after (B, b) photo-bleaching of PKCα in an unstimulated control cell. The
line scan was performed in an axis arbitrarily chosen to bisect the nucleus,
extending to the visible borders of the cell (top panel); whereas, the bottom
panel shows the results. β-tubulin was visualized using a monoclonal antiβ-tubulin clone TUB2.1 FITC-labeled antibody. PKCα was visualized
using a monoclonal anti-PKCα clone M4 primary antibody followed by
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Alexa 546-labeled secondary antibody. The basal image of β-tubulin
emission was obtained by excitation with the 488nm-laser line at 10%
power (A). The cell and surrounding area were then excited with the
568nm-laser line at 100% power to photo-bleach all traces of PKCα-Alexa
546 emission. Immediately following photo-bleaching, a second β-tubulin
image was captured with the 488nm-laser line (B) at the exact settings
utilized in basal imaging. According to FRET theory, donor molecule (βtubulin) emission is expected to increase in the absence of the acceptor
molecule (PKCα). The images represent results obtained in 3 individual
experiments in which a total of 20 cells were evaluated.
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Figure 6.

Line scan analysis showing β-tubulin emission intensity before (A, a) and
after (B, b) photo-bleaching of PKCα in a PDBu-stimulated cell. The line
scan was performed in an axis arbitrarily chosen to bisect the nucleus,
extending to the visible borders of the cell (top panel); whereas, the bottom
panel shows the results. β-tubulin was visualized using a monoclonal antiβ-tubulin clone TUB2.1 FITC-labeled antibody. PKCα was visualized
using a monoclonal anti-PKCα clone M4 primary antibody followed by
Alexa 546-labeled secondary antibody. The basal image of β-tubulin
60

emission was obtained by excitation with the 488nm-laser line at 10%
power (A). The cell and surrounding area were then excited with the
568nm-laser line at 100% power to photo-bleach all traces of PKCα-Alexa
546 emission. Immediately following photo-bleaching, a second β-tubulin
image was captured with the 488nm-laser line (B) at the exact settings
utilized in basal imaging. According to FRET theory, donor molecule (βtubulin) emission is expected to increase in the absence of the acceptor
molecule (PKCα). The images represent results obtained in 3 individual
experiments in which a total of 20 cells were evaluated.
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Figure 7.

The effect of colchicine on microfilaments and intermediate filaments.
Unstimulated A7r5 cells were incubated with vehicle (Control) or 40µg/ml
colchicine for 20 minutes prior to fixation and staining. Actin stress fibers
were visualized by staining with a monoclonal anti-α-smooth muscle actin
clone 1A4 FITC-labeled antibody. Intermediate filaments were imaged
using a monoclonal anti-vimentin clone V9 primary antibody followed by
Alexa 488-labeled secondary antibody. The results indicate that colchicine
had no significant effect on actin or intermediate filament structure. Images
are representative of those obtained in 3 individual experiments in which a
total of 150 to 175 colchicine-treated cells were evaluated.
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Figure 8.

The time course of colchicine-induced dissolution of microtubular structure
in A7r5 cells. Cells were untreated (vehicle control) or were incubated with
40µg/ml colchicine for 5, 10, or 20 minutes prior to fixation and staining.
Microtubules were imaged using a monoclonal anti-β-tubulin clone TUB2.1
FITC-labeled antibody. Images are typical of those obtained in four
separate experiments in demonstrating the dissolution of the dense network
of microtubules surrounding the nucleus (arrows) in advance of significant
losses in peripheral structure.
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Figure 9.

Topographical evaluation of the dense network of microtubules surrounding
the nucleus in an untreated control cell using atomic force microscopy
(AFM). The top panel shows a three-dimensional view of a contact AFM
image obtained from an unstimulated, fixed A7r5 cell. The bottom panel
shows a line scan of the cell indicating cross-sectional structure and
representative of cell height in the nuclear area. The image is representative
of those obtained in 3 individual experiments in which a total of 10 cells
were evaluated.
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Figure 10. Topographical evaluation of a colchicine-treated control cell using atomic
force microscopy (AFM). The top panel shows a three-dimensional view of
a contact AFM image of an unstimulated control cell incubated with
40µg/ml colchicine prior to fixation. The bottom panel shows a line scan of
the cell indicating cross-sectional structure and representing cell height in
the nuclear area. The image is representative of those obtained in 3
individual experiments in which a total of 10 cells were evaluated.

67

68

Figure 11. Topographical evaluation of the peri-nuclear microtubular sleeve in a
PDBu-contracted A7r5 cell using atomic force microscopy (AFM). The cell
was incubated with 10-6M PDBu prior to fixation. The top panel shows a
three-dimensional view of a contact AFM image of the cell after PDBu
treatment. The bottom panel shows a line scan of the image indicating
cross-sectional structure and representative of cell height in the nuclear area.
The image is representative of those obtained in 3 individual experiments in
which a total of 10 cells were evaluated.
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Figure 12. Topographical evaluation of the peri-nuclear microtubule sleeve in a PDBucontracted A7r5 cell incubated with colchicine. The cell was incubated with
10-6M PDBu after which 40µg/ml colchicine was added for an additional 30
minutes prior to fixation. The top panel shows a three-dimensional view of
a contact AFM image of the cell. The bottom panel shows a line scan of the
image indicating cross-sectional structure and representative of cell height in
the nuclear area. The image is representative of those obtained in 3
individual experiments in which a total of 10 cells were evaluated.
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Figure 13. A model developed from measurements of control and colchicine-treated
cells describing the three-dimensional structure of the peri-nuclear
microtubule sleeve. The cartoon depicts untreated (a, b) and colchicinetreated (c, d) cells indicating the absence of the microtubular structure after
colchicine. The table provides a summary comparison of cell dimensions in
control and PDBu-activated cells. Direct measurements include cell height
in untreated (control) (1) and colchicine-treated (5) cells, sleeve diameter (4)
and sleeve thickness (3). The sleeve height was obtained by subtracting the
average ground substance height of colchicine-treated cells (5) from the
height of individual control cells (1). Sleeve volume was calculated using
the averaged cell measurements and assuming the shape of the structure was
similar to a hollow cylinder. With the exception of sleeve volume, the
values presented represent the mean ± SEM of 10 cells.
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Table 1. FRET distances calculated from whole cell emission scans and line scans of
selected cell regions in unstimulated (control), phorbol 12, 13 dibutyrate
(PDBu)-stimulated, and colchicine-treated cells.
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A. Whole Cell
N

Fret Distance, Å

Control

15

89.2 ± 6.8

Control + Colchicine

15

80.7 ± 2.8

PDBu

15

99.9 ± 4.6

PDBu + Colchicine

15

90.2 ±2.9

B.

Regional
1. Peri-Nucleus vs. Periphery
PeriN

Periphery
Nucleus

Control

20

72.8 ± 1.7

87.3 ± 2.6*

PDBu

20

72.9 ± 1.8

95.8 ± 4.3*

2. Tubulin/PKCα “Hot Spots”
N

FRET Distance, Å

Control

20

61.4 ± 1.1

Control + Colchicine

20

59.6 ± 1.8

PDBu

20

59.8 ± 4.4

PDBu + Colchicine

20

59.7 ± 2.3

An (*) indicates significant difference peri-nucleus vs. periphery (p<0.05 or greater). “Hot Spots”
refer to points of maximal efficiency of energy transfer (E) obtained from line scans. N = number of
cells evaluated.
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Discussion

Our results confirm earlier findings that treatment of cells with colchicine to disrupt
microtubules blocks the translocation of PKCα to the peri-nucleus (23, 1, 18). Based on
this finding, it was suggested that microtubules could influence both the movement of
PKCα to the peri-nucleus and/or the docking mechanism in this region of the cell (1).
We further show that treatment of preactivated cells in which translocation is complete
with colchicine causes dispersal of PKCα back into the cytosol (Fig. 1). This suggests
that the principal impact of the microtubules is not on the actual movement of PKCα but
that they act to stabilize the aggregation of the enzyme in different regions of the cell. In
previous work utilizing a PKCα -GFP fusion protein expression, we were not able to
clearly demonstrate a direct relationship between PKCα and microtubules in A7r5 cells
(18). However, we now show that dual immunostaining for PKCα and β-tubulin with
confocal microscopic imaging (Fig. 3) and analysis of overlapping emission/excitation
spectra by FRET microscopy (Fig. 4-6, Table 1) indicate significant co-localization and
close association of PKCα with microtubules in both unstimulated control and PDBustimulated A7r5 cells. The present finding that association of PKCα with tubulin does
not require cell stimulation suggests that the activation of the enzyme is not necessary for
interaction between the two molecules. Alternatively, these results may reflect a basal
level of PKCα activity in resting cells. Evidence that PKCα is associated with tubulin in
colchicine-treated cells (Fig. 4, Table 1) further indicates that PKCα may complex with
tubulin in the cytosol.
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It is noteworthy that both confocal imaging (Fig. 3) and FRET analysis (Fig. 4) indicate a
heterogeneous distribution of PKCα in association with microtubules. Visual inspection
of whole cell images suggests that the interaction is primarily confined to the central
region whereas the microtubular structure at the cell periphery appears devoid of PKCα.
FRET measurements (Table 1) verified a predominance of tubulin/PKCα interaction in
the region immediately adjacent to the nucleus and further indicated the existence of
discrete focal points of intense resonance energy transfer. The FRET distances calculated
for these “hot spots” of maximal tubulin/PKCα interaction are within the range of values
reported for other inter-molecular interactions (22) and could be indicating the direct
binding of PKCα with tubulin. However, the magnitude of the FRET distance recorded
could also be consistent with the association of β-tubulin and PKCα via a linker protein.
In view of the highly restricted compartmentalization of the tubulin/PKCα interaction,
we consider it unlikely that PKCα is constitutively bound to tubulin. It must be
emphasized that the results do not allow quantitation of PKCα/microtubule association
and the possibility remains that a portion of PKCα is associated with other structure in
the peri-nuclear region. Taken together, however, the results suggest that the
microtubules could act as a scaffold for PKCα binding. This function is primarily
confined to the peri-nuclear microtubular structure and occurs through an interaction of
PKCα with microtubule-associated compounds.

In comparison with other cytoskeletal components, the microtubules of the A7r5 cell
form a unique structural configuration, as seen with confocal microscopy (Fig. 2). A
dense network about the nucleus is connected by thick cables radiating across the cell
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body to a dense network of microtubules lying under the plasmalemma. Interestingly, a
highly reproducible sequence of colchicine-induced dissolution of microtubular structure
was observed in these various regions of the cell (Fig. 8). There was initial loss of the
central peri-nuclear network with complete disassembly realized by 5 min. after
colchicine addition. By comparison, significant loss of radiating cables occurred at 10 to
20 min, whereas the subplasmalemma network of microtubules was often at least
partially intact after 20 min. of colchicine treatment. Because colchicine is thought to
prevent polymerization by binding tubulin subunits, the high level of colchicine
sensitivity suggests that microtubular structure in the peri-nuclear region is more
dynamically robust than in other regions of the cell.

Topographical analysis of fixed cells by AFM indicated that the peri-nuclear network of
microtubules formed an elevated sleeve-like structure enveloping the nucleus (Fig. 9, 10).
A similar evaluation of PDBu-activated cells indicated that the dimensions of the perinuclear sleeve were significantly altered during cell shortening (Fig. 11, 12). By utilizing
measurements of height, thickness and diameter (Fig. 13), we calculated the volume of
the sleeve assuming a form roughly the shape of a hollow cylinder. This estimate
indicated that the volume of the microtubular sleeve was approximately 4.9µm3 in control
cells and 25.5 µm3 in cells treated with PDBu. Differences in microtubular volume
between control and PDBu-stimulated cells could reflect an artifact of colchicine
treatment or sample preparation for imaging. Alternatively, the 5-fold increase observed
in PDBu-treated cells could represent an increase in microtubular mass in the activated
cells. As previously noted, the interaction between PKCα and β-tubulin was retained
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after treatment with colchicine, suggesting that PKCα may associate with monomeric or
small aggregates of tubulin in the cytosol. The possibility occurs that such a
tubulin/PKCα complex is translocated to the peri-nucleus during expansion of the
microtubular structure in this region during cell activation.

Activation of PKCs has been shown to result in changes in cytoskeletal structure in
association with the phosphorylation of an array of cytoskeletal proteins (12). It is well
documented that PKCs may interact with each of the cytoskeletal components with some
evidence to suggest increased activity in the activated cell (9). Hence, there is a large
literature on the role of PKCs in cytoskeletal regulation. However, the great bulk of
research has focused on regulation of actin microfilaments (12) and relatively little is
known of the role of PKC in microtubule dynamics. Kabir et al. (2001) have reported the
interesting finding that activation of PKC by phorbol esters in Aplysia bag cell neurons in
primary cell culture resulted in a doubling in the length of a typical microtubule growth
episode while increasing and decreasing rescue and catastrophe frequencies, respectively.
They concluded that PKC may play an important role in regulating cellular processes
involving directed microtubular growth. This group (21) has subsequently shown
phorbol ester-induced translocation of PKCs to microtubules, suggesting a direct role of
these kinases in the regulation of distal microtubular advance in neural growth cones.
Their findings open the possibility that the translocation of PKCα to the peri-nuclear
microtubules in A7r5 cells could serve a regulatory function directed toward
microtubular growth and stability in this region of the cell. This function, in turn, would
appear consistent with increased dynamic activity evidenced by colchicine sensitivity and
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the increase in volume of peri-nuclear microtubular structure in the present study.
Alternatively, the translocation of PKCα could reflect a specialized role of peri-nuclear
microtubules as a scaffold for interaction of regulatory molecules influencing a variety of
cell functions in the central region of the cell. There is evidence from a variety of cell
types suggesting a link between PKC-mediated function and the capacity for microtubule
reorganization. For example, the prevention of microtubular depolymerization with taxol
blocked PKC (phorbol ester)-induced NF-kappa B activation in murine NIH3T3 cells
(24) while causing hyperphosphorylation of vimentin and reorganization of the
intermediate filament cytoskeleton via a PKC signaling pathway in 9L rat brain tumor
cells (3). Others (25) have proposed that microtubule catastrophe may be obligatory for
PKC (phorbol ester)-mediated MCL1 gene expression in the MCL1 human myeloblastic
leukemia cell line. As a matter of speculation, a dynamic microtubular scaffold could
serve to compartmentalize regulatory interactions while providing for rapid and
potentially directional expansion during growth of structure and the reduction of
interaction or compartmentalized release of compounds during catastrophe and loss of
structure.

In summary, the results confirm earlier conclusions that the microtubular cytoskeleton is
required for PDBu-induced localization of PKCα at the peri-nuclear region in A7r5
smooth muscle cells. The results suggest that this is due to an association of activated
PKCα with microtubule-associated compounds confined to the microtubules in this
region of the cell. In addition to the regional limitation of PKCα localization, the
distribution of microtubular structure in the cell and differences in colchicine sensitivity
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suggest that microtubules in the peri-nuclear region represent a distinct subpopulation
which may differ in their dynamic growth characteristics from those in other regions.
PKC could be an important factor in determining these characteristics. Alternatively, the
peri-nuclear microtubules could serve as a scaffold for interaction of regulatory proteins
at the cell center.
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Abstract
Aim: The effects of changes in the expression levels of h1 calponin (CaP) on actin
cytoskeletal organization were studied in control and phorbol-ester-treated A7r5 smooth
muscle cells.
Methods: Protein association and expression in control and stimulated A7r5 smooth
muscle cells were evaluated by Western blotting, laser scanning confocal microscopy
(LSCM) and fluorescence resonance energy transfer (FRET) microscopy in cells treated
with either 2x10-6M TGF-β1 or 2x10-5M PDGF-BB to alter h1 calponin expression.
Results: Single immunostained samples showed that CaP and α-actin, localized in fibers
in unstimulated control A7r5 smooth muscle cells, were translocated to podosomes
following treatment with phorbol-12, 13-dibutyrate (PDBu). Confocal colocalization
imaging and FRET analysis both indicated substantial association of CaP with α-actin in
stress fibers of control cells and in podosomes of PDBu-treated cells. PKCα, which
showed evidence of only slight association with CaP in control cells, exhibited markedly
increased (293%) association in PDBu-contracted cells. Platelet-derived growth factor
(PDGF)-BB down-regulated (non-detectable) while transforming growth factor (TGF)-β1
up-regulated (424%) the expression of CaP without affecting the levels of α-actin or
PKCα. PDGF-BB resulted in a significant loss in α-actin stress fibers (-47%) and
prevented podosome formation (-69%). By comparison, TGF-β1 had no effect on stress
fibers in control cells but also reduced (-70%) podosome formation.
Conclusions: The results suggest that CaP could play a major role in the stabilization of
actin stress fibers in resting cells and may contribute to podosome formation in PDButreated cells.
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Introduction
Calponin (CaP) is a 34-kDa protein expressed in smooth muscle but not in
skeletal or cardiac muscle types (Takahashi et al. 1987). CaP has been linked to the
regulation of smooth muscle contractility through its ability to inhibit Mg2+-ATPase
activity (Winder and Walsh 1990) and reduction of unloaded shortening velocity without
effect on isometric force (Jaworowski et al. 1995; Obara et al. 1996). Conversely,
increased velocity of shortening is seen in smooth muscle from CaP-gene knockout mice
(Matthew et al. 2000). Attempts to understand the mechanism underlying the influence
of CaP on contractility have focused on the protein binding properties of the molecule.
CaP contains binding sites for both actin and myosin as well as calmodulin and desmin
(Szymanski 2004). The combination of desmin and actin binding has prompted
speculation that CaP could play a structural role serving in cytoskeletal organization
which influences the mechanical properties of the cell (Lehman 1986; Kolakowski et al.
1995). It is further proposed that actin/myosin binding properties of CaP could tether
these filaments, imposing an internal load to brake velocity of contraction which,
combined with the inhibitory effect of CaP on Mg2+-ATPase activity, could underlie
latch-bridge activity in smooth muscle (Szymanski 2004).
Kolakowski et al. (1995) have reported evidence indicating that CaP contains two
actin binding sites; one at amino acid residues 145-182 (El-Mezgueldi et al. 1992) and
another at residues 48-134 which exhibits sequence similarity to the actin binding region
of several actin-binding proteins (Vancompernolle et al. 1990). Interestingly, in the
presence of CaP actin filaments formed highly ordered actin bundles similar in
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appearance to stress fibers and at a CaP: actin molar ratio of about 0.5: 1.0. As observed
by Kolakowski et al. (1995), formation of actin bundles could be related to CaP
oligomerization and precipitation but was more likely due to direct CaP cross-linking of
filaments. Moreover, it was observed that CaP binding and actin bundling were reversed
by Ca2+/calmodulin. These results suggest that CaP could play an active role in the
stabilization/destabilization of actin cytoskeletal structure during contractile remodeling
of the cell. Consistent with this idea, Gimona et al. (2003) have reported that two
functionally distinct populations of actin fibers occur in phorbol ester-contracted A7r5
smooth muscle cells. Actin stress fibers decorated with h1 CaP remained stable;
whereas, those decorated with SM22-α disassembled and reorganized at podosomes,
suggesting a direct role of CaP in actin remodeling dynamics.
In the present study, we examined the effects of changes in the expression levels
of CaP on actin cytoskeletal structure in unstimulated and PDBu-treated A7r5 smooth
muscle cells. The results suggest that CaP is required for stability of actin stress fibers in
resting cells; whereas, excessive CaP concentrations inhibit actin remodeling in PDBustimulated cells. Based on these findings, we propose the hypothesis that actin bundling
by CaP represents an important mechanism for stabilization of actin structure and the
controlled release of actin filaments for sliding filament force development and actin
cytoskeletal remodeling in the contracting cell.
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Material and Methods
Cell Culture: A7r5 cells, originally derived from embryonic rat aorta and exhibiting an
adult smooth muscle phenotype (Firulli et al. 1998) were obtained from American Type
Culture Collection (Manassas, VA) and cultured in Dulbecco’s modified Eagle’s medium
(DMEM) that was supplemented with 10% fetal bovine serum and 100 units/ml penicillin
G. Cultures were maintained in a humidified atmosphere of 5% CO2 in air and allowed
to grow to approximately 85% confluence. The medium was changed every two days
and cells were passaged at least once a week. Cells were detached from culture plates by
the addition of a trypsin/EDTA solution in phosphate buffered saline (PBS).

Cell Treatments: A7r5 cells were incubated with either PDGF-BB or TGF-β1 to downregulate (Hautmann et al. 1999) or up-regulate (Sugenoya et al. 2002) the expression of
calponin h1, respectively. Cells were plated on Integrid style tissue culture dishes
(Becton, Dickinson and Co., Cockeysville, MD) and prior to growth factor addition,
growth was arrested by replacement of media with DMEM supplemented with 0.5% fetal
bovine serum. PDGF-BB (2x10-5M) and TGF-β1 (2x10-6M) were added and in initial
experiments, cells were harvested at selected intervals for Western blotting analysis to
determine the optimal time for study of changes in CaP, α-actin, and PKCα expression.
Based upon these experiments, PDGF-BB-treated cells at 48 hours and TGF-β1 cells at
12 hours were selected for further study.
For imaging studies, cells were plated onto 22mm x 22mm #1 glass cover slips
placed in six well culture plates and returned to the incubator for a minimum of 24h to
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allow for attachment and spreading. Cells were growth arrested (24h) followed by 48h
incubation with PDGF-BB or 12h incubation with TGF-β1. During these intervals
control cells received vehicle. After incubation cells were left unstimulated or were
contracted by the addition of PDBu (10-5M). The cells were then fixed and
permeabilized for imaging by addition of ice-cold acetone for 1.0 minute.

Confocal/FRET Microscopy: Following fixation in acetone, the cells were repeatedly
(3X) rinsed with PBS containing 0.5% TWEEN-20 (PSB-T), pH 7.5, and were then
incubated for 1h in blocking solution (5% nonfat dry milk in PBS). α-Actin was imaged
using a monoclonal anti-α-smooth muscle actin clone 1A4 antibody (Sigma Chemical
CO., St. Louis, MO). PKCα was imaged using a whole antiserum anti-PKCα antibody
(Sigma Chemical Co.) and CaP was visualized using a monoclonal anti-CaP clone hCP
antibody (Sigma Chemical Co.). Incubation with unlabeled primary antibodies was
followed by incubation with a 1:150 dilution of the appropriate IgG or IgM secondary
Alexa Fluor 488 or Alexa Fluor 546 antibody (Molecular Probes, Inc., Eugene, OR) for
1h at room temperature.
Immunostained cells were mounted on a Nikon Diaphot microscope and confocal
microscopy was performed with a BioRad Model 1024 Scanning system equipped with a
krypton/argon laser. For FRET analysis CaP was labeled with Alexa 488 (excitation
488nm; emission 520nm) and served as the donor component of the system. α-Actin and
PKCα were labeled with Alexa 546 (excitation 546nm: emission 580nm) and served as
the acceptor molecules. The donor molecule (CaP) was directly excited and the resulting
emission obtained with a 522 DF 32 band-pass filter. However, a portion of the energy
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of emission was not released as light but was transferred to neighboring Alexa 546
fluorophore resulting in emission that was captured on a second channel with an HQ
598/40 band pass filter. Subsequently, the sample was excited at the 568nm laser line at
100% power to photobleach the acceptor (PKCα, α-actin) molecule and a second image
of the cell was acquired again at the 488nm laser line with the multichannel set to obtain
CaP fluorescence (522 DF 32) and to verify the absence of acceptor label Alexa 546
emission (HQ 598/40). An intensity profile was generated for each image (Image J
Software, NIH) and the resulting plot was analyzed with Peakfit v4.11 software (SPSS
Science, Richmond, CA) to obtain the area under the curve. The values were then used
to calculate the percent increase in fluorescence after photobleaching. Because resonance
energy transfer can only occur if the donor and acceptor molecules are sufficiently close
to one another for efficient transfer, the resulting values were analyzed in comparisons of
treated and control cells as an index of the association between CaP and the other
proteins in unstimulated and PDBu-contracted cells.
α-Actin stress fiber density was evaluated as previously described (Black et al.
2006). Images of treated and control cells were obtained at fixed confocal settings and
analyzed using Image J software (NIH). Utilizing the line scan tool, the cell was bisected
perpendicular to the long axis at mid-cell and the resulting plot was imported into
Microsoft Office Excel. The point of lowest intensity was selected as baseline and its
plot was then analyzed using Peakfit v411 software to determine the area under the curve
(I = total intensity). This value was then divided by line pixel number (p) to normalize
for line length. The final value (I/p) was calculated using Excel. To evaluate cells
responding to PDBu by formation of podosomes, cell counts were performed in three
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independent experiments totaling a minimum of 300 cells. Cells were scored by two
viewers and the counts were averaged.

Western Blot Analysis: Treated cells were detached from tissue culture dishes by the
addition of a 1:10 trypsin/EDTA solution in phosphate-buffered saline (PBS). The
solution was placed in a 15ml conical tube and subjected to centrifugation in a Fisher
Scientific Centrific Model 228 clinical centrifuge (Pittsburgh, PA). The resulting pellet
was collected and resuspended in 500µl RIPA buffer containing a Complete Mini
protease inhibitor cocktail tablet (Roche Diagnostics, Mannheim, Germany). These
lysates were further disrupted by 10 second bursts from a Teckman sonic disrupter (Cole
Parmer Instrument Co., Vernon Hills, IL) at power setting 60. The samples were then
centrifuged at 5,000 rpm/min for 2 minutes to remove cellular debris and protein
concentrations in the supernatant were determined by the BCA® (Pierce, Rockford, IL)
protein assay. Fifty µl of each treatment sample were loaded onto an 8% sodium dodecyl
sulfate polyacrylamide gel (SDS-PAGE) and the separated proteins electrically
transferred to 0.45µm polyvinylidene difluoride (PVDF) transfer membrane (Pierce,
Rockford, IL). The membrane was incubated in a 5% non-fat dry milk/PBS blocking
solution for 1 hour at room temperature and after multiple 5-minute washes with
PBS/0.5% TWEEN (3X), the membrane was incubated for 1 hour with either a 1:500
dilution of monoclonal anti-α-smooth muscle actin clone 1A4 antibody (Sigma Chemical
Co., St. Louis, MO), a 1:200 dilution of whole antiserum anti-PKC α antibody (Sigma
Chemical Co., St. Louis, MO), a 1:500 dilution of monoclonal anti-calponin clone hCP
antibody (Sigma Chemical Co., St. Louis, MO), or a 1 µg/ml solution of a monoclonal
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antibody to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Ambion, Inc.,
Austin, TX).

This was followed by incubation with the appropriate secondary antibody:

peroxidase-labeled goat anti-rat IgM affinity purified antibody (Kirkegaard and Perry
Laboratories, Gaithersburg, MD), anti-mouse Ig, horseradish peroxidase-linked whole
antibody (sheep), or ECL™ anti-rabbit IgG horseradish peroxidase-linked whole
antibody (donkey) (Amersham Biosciences UK Limited, Buckinghamshire, England).
Reactive bands were visualized by the ECL™ chemiluminescence method (Amersham,
Piscataway, NJ) using CL-Xposure™ Clear Blue X-ray film (Pierce, Rockford, IL).
Resultant bands were evaluated via densitometry using Image J Software (NIH) with the
resulting plot analyzed using Peakfit v4.11 software (SPSS Science, Inc., Richmond, CA)
to obtain the area under the curve. To standardize these areas the values obtained were
divided by the corresponding GAPDH values and the respective control groups were
normalized to a value of 1.00.

Statistical Analysis: Results were analyzed by Sigma Stat 2.03 (SPSS Inc., Richmond,
CA) using one-way ANOVA and Student’s t-test in comparisons of values obtained for
control cells with those stimulated with PDBu in untreated and TGF-β1 or PDGF-BB
treated groups. Values are presented as mean ± SEM throughout the text.
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Results
Single immunostaining for individual proteins in unstimulated control cells
indicated that α-actin and CaP localized in stress fibers while PKCα was distributed in a
network pattern previously shown to be in association with β-tubulin (Dykes et al.
2003)(Fig. 1). PDBu-stimulated cells showed a loss in stress fibers with translocation of
α-actin and CaP to podosomes, while PKCα appeared to be diffusely distributed in the
perinuclear region of PDBu-treated cells (Fig. 1). Co-localization imaging suggested a
strong association of α-actin and CaP in stress fibers of control cells and in podosomes of
PDBu-treated cells (Fig. 2). There was little or no evidence of co-localization of PKCα
and CaP in control cells. However, these proteins appeared strongly associated in
podosomes but not stress fibers of PDBu-contracted cells (Fig.3). FRET analysis
confirmed the association of α-actin and CaP seen in co-localization images of control
and PDBu-treated cells, further indicating a slight (-22%) decrease in α-actin/CaP
complex in PDBu compared to control cells (Table 1). Similar to co-localization results
FRET analysis indicated insignificant PKCα/CaP association in control cells. However,
the association of these proteins was significantly increased (293%) in PDBu-contracted
cells.
Incubation of A7r5 cells with TGF-β1 resulted in an approximate 5-fold increase
in CaP protein content at 12 hours (Fig. 4, Table 2A) without significant changes in αactin or PKCα levels. Conversely, PDGF-BB caused the down-regulation of CaP to
levels below detection (Fig. 4, Table 2B) without significant changes in α-actin or PKCα
content. Although the CaP content of stress fibers increased nearly 2-fold, α-actin fiber
density was unchanged in TGF-β1-treated control cells (Fig. 5, Table 3A). In contrast,
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PDGF-BB down-regulation of CaP resulted in significant loss in α-actin stress fiber
intensity (-47%).
Approximately 85% of PDBu-treated cells showed relocalization of α-actin at
podosomes (Fig. 5, Table 3B). By comparison, cells treated with either TGF-β1 or
PDGF-BB showed reduced (-70%) podosome formation (Table 3B). TGF-β1-treated
cells maintained a robust system of α-actin stress fibers in the presence of PDBu;
whereas, this structure was only weakly developed in PDGF-BB incubated cells (Fig. 5).
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Figure 1. Immunostaining of α-actin, PKCα, and calponin in unstimulated (control) and
PDBu-activated A7r5 cells. Cells were treated with 10-5M PDBu for 20 minutes before
acetone fixation. α-Actin was visualized with a monoclonal anti-α-smooth muscle actin
clone 1A4 antibody. Calponin was visualized using a monoclonal anti-calponin clone
hCP antibody. These treatments were followed by anti-mouse Alexa 488 secondary
antibody. PKCα was visualized with whole antiserum anti-PKC α antibody, followed by
anti-rabbit Alexa 546 secondary antibody.
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Figure 2. Dual immunostaining of α-actin and calponin in unstimulated (control) and
PDBu-activated A7r5 cells. α-Actin was visualized with a monoclonal anti-α-smooth
muscle actin clone 1A4 antibody followed by Alexa 488 secondary antibody. Calponin
was visualized using a monoclonal anti-calponin clone hCP antibody followed by Alexa
546 secondary antibody. Yellow color in merged panels indicates colocalization of the
two proteins.
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Figure 3. Dual immunostaining of calponin and PKCα in unstimulated (control) and
PDBu-activated A7r5 cells. Calponin was visualized with a monoclonal anti-calponin
clone hCP followed by Alexa 488 secondary antibody. PKCα was visualized using a
whole antiserum anti-PKCα antibody followed by Alexa 546 secondary antibody.
Yellow color in merged panels indicates colocalization of the two proteins.
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Figure 4. Western blot analysis of PKCα, α-actin, and calponin content in A7r5 cells
treated with TGF-β1 and PDGF-BB. A7r5 cells were grown to confluence, then growth
arrested for 24 hours. TGF-β1-treated cells were exposed to 2x10-6M TGF-β1 for 0
(control), 6 or 12 hours before collection. PDGF-BB-treated cells were exposed to 2x105

M PDGF-BB for 0 (control), 24 or 48 hours before collection. Sample preparation

included homogenization and BCA protein concentration determination prior to SDSPAGE. After the proteins were electrically transferred to PVDF membrane, calponin, αactin, PKCα, and GAPDH bands were probed with monoclonal anti-calponin clone hCP,
monoclonal anti-α-smooth muscle actin clone 1A4, whole antiserum anti-PKCα, or
monoclonal antibody to glyceraldehyde-3-phosphate dehydrogenase primary antibodies,
respectively. This was followed by incubation with the appropriate secondary antibody:
anti-mouse Ig, horseradish peroxidase-linked whole antibody (sheep), or anti-rabbit IgG
horseradish peroxidase-linked whole antibody (donkey). Reactive bands were visualized
by the ECL™ chemiluminescence method.
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Figure 5. Immunostaining of α-actin in unstimulated (control) and PDBu-activated A7r5
cells incubated with TGF-β1 or PDGF-BB. TGF-β1-treated cells were exposed to 2 x 106

M TGF-β1 for 12 hours. PDGF-BB-treated cells were exposed to 2 x 10-5 M PDGF-BB

for 48 hours. Cells were stimulated to contract by addition of 10-5M PDBu for 20
minutes. α-Actin was visualized with a monoclonal anti-α-smooth muscle actin clone
1A4 antibody followed by anti-mouse Alexa 488 secondary antibody.
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Figure 6. A proposed role of CaP in the controlled release of bundled actin filaments for
interaction with myosin and subsequent remodeling during cell contraction. Stimulation
with activation of myosin light chain kinase (MLCK) or PKC-mediated activation of the
Rho cascade to inhibit myosin light chain phosphatase would initiate force development.
In addition, CaP disassociation from actin would occur at Ca2+/CaM sensitive sites or
phosphorylation at Ser175 resulting in the reversal of Mg2+-ATPase activity and
unbundling of actin filaments. The combined activities would ensure the strategic
availability of actin filaments for interaction with myosin and enable subsequent actin
remodeling during cell constriction.
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Table 1. FRET Analysis of the association of calponin with α-actin and PKCα in Control
and PDBu-treated A7r5 smooth muscle cells. In each case calponin served as the donor
molecule. Data are presented as percent increase in fluorescence intensity after
photobleaching of the acceptor molecule. Values reflect the average from a minimum of
ten cells in three independent experiments.
Treatment

α-Actin

PKCα

Control

41.6 ± 12.2

2.9 ± 0.6

PDBu

32.8 ± 7.0

11.4 ± 2.5*

An asterisk (*) indicates significant difference from the control value, p < 0.05 or better.
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Table 2. Western blot analysis of PKCα, α-actin, and calponin content in A7r5 cells at
different time intervals during treatment with cytokine TGF-β1 (A) or PDGF-BB (B) to
up-regulate or down-regulate calponin expression, respectively. Data are presented as
percent of control values and represent the average of three independent experiments.

A) TGF-β1
Control

6 hr

12 hr

PKCα

100 ± 0

130 ±14

202 ± 78

α-actin

100 ± 0

102 ± 21

101 ± 20

Calponin

100 ± 0

377 ± 47*

524 ± 163*

Control

24 hr

48 hr

PKCα

100 ± 0

71 ± 15

90 ± 10

α-actin

100 ± 0

94 ± 6

99 ± 11

Calponin

100 ± 0

85 ± 7

0*

B) PDGF-BB

An asterisk (*) indicates significant difference from the control value, p < 0.05 or better.
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Table 3. Effect of TGF-β1 and PDGF-BB induced changes in cell expression of
calponin on A) α-actin and calponin fiber density in control cells B) podosome
formation in PDBu-treated cells. Cell density data reflects fluorescent intensity per
pixel whereas data from PDBu-contracted cells indicates the percentage of cells
showing podosome formation. Values represent the average of fiber density
measurements in a minimum of 10 cells and podosome counts in a minimum of 300
cells obtained in three independent experiments.

A) Cell Fiber Density
Treatment

α-actin

Calponin

Control

85.7 ± 7.8

33.0 ± 1.0

TGF-β1

84.3 ± 6.1

64.4 ± 4.7*

PDGF-BB

45.8 ± 5.2*

0*

B) Podosome Formation

% Cells

PDBu Only

TGF-β1

PDGF-BB

84.0 ± 1.0

26.0 ± 4.0*

26.5 ± 2.5*

An asterisk (*) denotes significant difference from the control (A) or PDBu only (B)
value, p < 0.05 or better
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Discussion
It is now generally accepted that the cytoskeletal structure of smooth muscle
undergoes reorganization which is thought to impact positively on force development.
However, the nature of this remodeling and the mechanisms by which it is regulated are
not certain. Previous work has demonstrated that contraction of A7r5 smooth muscle
cells with PDBu results in a loss of α-actin stress fibers with translocation of α-actin to
podosomes (Fultz et al. 2000; Black et al. 2006), an event mediated by PKCα (Hai et al.
2002; Gatesman et al. 2004). Recent work has further shown that actin fibers decorated
with CaP were stable during PDBu stimulation (Gimona et al. 2003), suggesting that this
protein could play a regulatory role in stress fiber stabilization or the translocation of
actin to podosomes.
In vitro studies indicate that CaP is phosphorylated by PKC or calmodulindependent kinase II (Winder and Walsh 1990) resulting in the loss of its ability to bind
actin and the ability to inhibit Mg2+-ATPase activity. Although there is controversy
surrounding how readily CaP is phosphorylated in vivo (Barany et al. 1991; Gimona et al.
1992) there is evidence that the molecule is transiently phosphorylated in contracting
tissue (Winder et al. 1993; Gerthoffer and Pohl 1994). Recent evidence has further
indicated a direct association of CaP and PKCα induced by acetylcholine in colonic
smooth muscle (Patil et al. 2004). Consistent with these latter observations; we obtained
evidence of significant PKCα/CaP association after PDBu addition. PKCα/CaP complex
appeared to be concentrated at podosomes and was not apparent in remaining stress
fibers. This coupled with our observation of only a slight decrease in α-actin/CaP in
contracted cells (Table 1) suggests that only a select portion of CaP could have been
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phosphorylated or otherwise induced to disassociate from α-actin. Alternatively,
PKCα/CaP complex may be involved in the translocation or assembly of proteins at the
podosome.
PDGF-BB has been shown to down-regulate CaP expression in non-muscle cells
(Sugenoya et al. 2002) with resultant changes in cytoskeletal organization (Heldin and
Westermark 1999). In A7r5 cells, treatment with this growth factor for 48h caused an
absence of detectable CaP expression without significant change in the levels of α-actin
or PKCα. It was expected that release from CaP inhibition would result in a degree of
basal cell constriction with attendant reorganization of the actin cytoskeleton. Instead,
we observed an approximate 50% loss in α-actin stress fibers in unstimulated control
cells and apparent loss in ability to respond to PDBu with cell constriction and podosome
formation. One explanation of these findings is that CaP is required for the structural
integrity of α-actin structure and the disruption of the contractile apparatus blocks
subsequent cell contraction and cytoskeletal remodeling.
TGF-β1 has been shown to promote the differentiation of several cell types to a
smooth muscle phenotype, prompting the up-regulation of actin, myosin, and CaP
(Hautmann et al. 1999; Sugenoya et al. 2002). In the A7r5 cell, 12h treatment with TGFβ1 caused an approximate 5-fold increase in CaP protein without significantly affecting
the expression levels of α-actin or PKCα. Both unstimulated and PDBu cells treated with
TGF-β1 showed robust α-actin stress fiber structure. Similar to PDGF-BB-treated cells,
however, these cells showed a marked decrease in PDBu-induced podosome formation.
In light of our present findings suggesting that only a small portion of the total CaP is
disassociated from α-actin during contraction, a possible explanation of reduced
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responsiveness to PDBu is excessive CaP stabilization of contractile structure and
inhibition of contraction.
CaP has long been known to influence the contractile properties of smooth
muscle, its mechanism primarily attributed to an ability to bind actin and myosin as well
as the inhibition on Mg2+-ATPase. We suggest that in addition to these actions the
capability of CaP to crosslink actin filaments plays a major physiological role in smooth
muscle contraction. Our present results suggest that CaP is required for the structural
integrity of at least a portion of the actin contractile cytoskeleton. Down-regulation of
CaP expression resulted in disruption of α-actin stress fibers and blocked subsequent
stimulation-induced remodeling of the cytoskeleton and podosome formation. In
addition, we find that over-expression of CaP is also associated with the inhibition of
actin remodeling and podosome formation, likely due to excessive CaP stabilization of
stress fibers. Hence, the results suggest that a balanced content of CaP is necessary for
stress fiber stability in the resting A7r5 smooth muscle cell and for normal constriction
and actin cytoskeletal remodeling in PDBu-activated cells. As shown in Figure 6, the
initiation of force development either by activation of myosin light chain kinase by
Ca2+/CaM complex or the Rho cascade by PKC to inhibit myosin light chain phosphatase
may be expected to additionally reverse CaP inhibition of Mg2+-ATPase and the
crosslinking of actin filaments through disassociation of CaP from actin at Ca2+/CaM
sensitive sites (Kolakowski et al. 1995) or due to phosphorylation of CaP at Ser175
(Winder et al. 1993). Reversal of CaP effects simultaneous with initiation of force
development would strategically enhance actin/myosin interaction at sites with individual
filaments available for movement by myosin.
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CHAPTER IV.
SUMMARY AND CONCLUSION
General Discussion
Early thinking on smooth muscle contraction centered on explaining the
contractile properties of this muscle type within the framework of existing models
developed to explain the mechanisms of skeletal muscle contraction. In recent decades, it
has become increasingly clear that smooth muscle contractility cannot be completely
explained by these comparisons. Although the notion of cytoskeletal remodeling has
provided a viable hypothesis for understanding the mechanics of the smooth muscle
contraction, many aspects of this phenomenon in terms of its nature and regulation also
remain unexplained. The body of this work focuses on the contributions of the PKC
family of proteins to cytoskeletal remodeling during the smooth muscle contraction
process.
Microtubules and their associated motor proteins, kinesin and dynein, are
important for intracellular transport. As the “tracks” for this efficient transfer system, the
microtubular array extends from the center of a cell to the outer periphery. The
distribution of these filaments in the cell gives microtubules the potential for interaction
with many cellular components and the possibility for influence on a variety of functions
within the cell through biologically active MAPs. Our present work demonstrated the
direct association of PKCα with β-tubulin, a major component of microtubules.
Surprisingly, this association remained intact in resting and stimulated cells, as well as
cells in which microtubules had been disrupted by colchicine, indicating an unusually
strong association. Additionally, it was also shown that PKCα’s translocation to its site
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of action is dependent on the microtubular system. When microtubules were disrupted by
dissolution with colchicine, PKCα remained diffusely distributed and did not translocate
to the nucleus, as observed in intact cells. Additionally, treatment with colchicine after
PKCα was stimulated to nuclear translocation caused a redistribution of PKCα
throughout the cell further indicating the role of microtubules in “fixing” the distribution
of this protein. This work represents important new findings and allows the introduction
of the novel hypothesis of a microtubular scaffold for the interaction and
compartmentalized release of PKCα, with the possibility of the involvement of additional
signaling molecules. Also, the methods described here represent pioneering work using
FRET microscopy and AFM in fixed biological samples.
CaP has long been known to inhibit Mg2+-ATPase activity and decrease the
velocity of shortening in smooth muscle. In vitro phosphorylation of calponin by PKCα
causes its dissociation from actin and relieves this inhibition. Previously, this
disinhibition by PKCα was viewed to be a switch, operating by a simple on or off
mechanism. The study here, however, has revealed that this is not necessarily the case.
In the present work, we obtained evidence indicating direct PKCα/calponin association in
A7r5 cells undergoing cytoskeletal remodeling and subsequent contraction. Moreover,
this work suggests that CaP is required for the structural integrity of at least a portion of
the actin cytoskeleton. Additionally, these results indicate that overexpression of CaP
prevents actin remodeling and podosome formation. These findings have led to the novel
hypothesis that CaP plays an important role in the stabilization of actin stress fibers in
resting cells and may contribute to podosome formation in PDBu-treated cells.
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Future Work
Studies to further this project would include the use of both general and
specific PKC inhibitors, such as staurosporine or GÖ6976, respectively, to examine
PKCα’s effects on both microtubule and calponin structure and function. It would be
important to ascertain if a PKC inhibitor could interrupt the static β-tubulin/PKCα
interaction described here. Additionally, blocking the growth of the microtubule-based
nuclear sleeve via a PKC inhibitor could ascribe a signaling complex involving PKCα and
β-tubulin, as well as contribute to assigning a more definite function for this novel
organelle. Similarly, it is possible that treatment with PKC inhibitors could produce
contractile effects similar to those seen with calponin up-regulation, by blocking
cytoskeletal remodeling and cellular contraction. Additionally, disinhibition with PKC
inhibitors in cells with down-regulated calponin levels could affirm our findings that the
observed effects are due to direct action of calponin and not a downstream consequence of
PKC signaling through another pathway.
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